| 1 | The dynamics of ubiquitination and its role within the proteome of extracellular vesicles | Coautor: Arrieta O., Morales-Tarré O., Popa-Navarro X., Paradela A., et al. | 2026 | JOURNAL OF PROTEOMICS | WoS-id: 001626807200001
Scopus-id: 2-s2.0-105022118600
| 0 | 0 |
| 2 | Cancer as trauma: multidimensional determinants of PTSD across the disease course. A narrative integrative review | Coautor: Arrieta O., Palomares-Palomares C.B., Rios-Garcia E., Hernandez-Martinez J.M., et al. | 2026 | FRONTIERS IN PSYCHOLOGY | WoS-id: 001664778300001
Scopus-id: 2-s2.0-105027895629
| 1 | 1 |
| 3 | Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy | Coautor: Arrieta O., Ramos-Ramírez M., Caballe-Pérez E., Lucio-Lozada J., et al. | 2025 | CANCER AND METASTASIS REVIEWS | WoS-id: 001414994100001
Scopus-id: 2-s2.0-85218290716
| 6 | 7 |
| 4 | SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1 | Coautor: Arrieta O., Trejo-Villegas O.A., Pineda-Villegas P., Armas-López L., et al. | 2025 | CANCER GENE THERAPY | WoS-id: 001425365700001
Scopus-id: 2-s2.0-85218172206
| 1 | 2 |
| 5 | Integrating healthcare utilization databases for cancer ascertainment in a prospective cohort in a limited resource setting: the Mexican Teachers? Cohort | Coautor: Arrieta O., Gómez-Flores-Ramos L., Brochier M., Stern D., et al. | 2025 | CANCER CAUSES & CONTROL | WoS-id: 001426336300001
Scopus-id: 2-s2.0-85218276279
| 2 | 2 |
| 6 | Cascade Testing Among Patients With Breast Cancer: Current Situation and Challenges in Latin America | Coautor: Arrieta-Rodriguez, OG, Alvarez-Gómez, RM, Garcilazo-Reyes, A, Avila-Moreno, F, et al. | 2025 | Jco Global Oncology | WoS-id: 001582474000001
Scopus-id: 2-s2.0-105017642301
| 0 | 0 |
| 7 | Correction: Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior (Cancers, (2021), 13, 24, (6256), 10.3390/cancers13246256) | Coautor: Arrieta O., Rodríguez-Bautista R., Caro-Sánchez C.H., Cabrera-Galeana P., et al. | 2025 | Cancers | WoS-id: 001594686900001
Scopus-id: 2-s2.0-105020025271
| 0 | 1 |
| 8 | Prognostic Factors in Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: Establishing the PLECH Baseline Risk Score | Coautor: Arrieta O., Guijosa A., Cabrera-Miranda L.A., Gómez-García A.P., et al. | 2025 | ONCOLOGY | WoS-id: 001633504100001
Scopus-id: 2-s2.0-105003464545
| 1 | 1 |
| 9 | Elucidating the Role of EGFRL858R in Brain Metastasis Among Patients With Advanced NSCLC Undergoing TKI Therapy | Coautor: Arrieta O., Rios-Garcia E., Guijosa A., Caballé-Perez E., et al. | 2025 | CLINICAL LUNG CANCER | Scopus-id: 2-s2.0-85216720850
| 0 | 2 |
| 10 | Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes | Coautor: Arrieta O., Caballé-Perez E., Hernández-Pedro N., Ramos-Ramírez M., et al. | 2024 | CLINICAL & TRANSLATIONAL ONCOLOGY | WoS-id: 001035531300002
Scopus-id: 2-s2.0-85165584269
| 4 | 4 |
| 11 | Implementation of a population-based cancer registry network in Mexico 2017-2020 | Coautor: Arrieta O., Mohar A., Paredes A., Brau-Figueroa H., et al. | 2024 | SALUD PUBLICA DE MEXICO | WoS-id: 001152521100024
Scopus-id: 2-s2.0-85179638780
| 3 | 3 |
| 12 | Lethal Prostate Cancer in Mexico: Data from the Can.Prost Mexican Registry and a Project for Early Detection | Coautor: Arrieta Rodriguez O.G., Jimenez Rios M.A., Scavuzzo A., Noverón N.R., et al. | 2024 | Cancers | WoS-id: 001352161600001
Scopus-id: 2-s2.0-85208581109
| 4 | 4 |
| 13 | Stigma in Mexican patients with Lung Cancer: Psychometric Properties of the Cataldo Lung Cancer Stigma Scale (CLCSS) - Brief version | Coautor: Arrieta, O, Flores-Juárez, J, Galindo-Vázquez, O, Ortega-Andeane, P, et al. | 2024 | PALLIATIVE & SUPPORTIVE CARE | WoS-id: 001360832200001
Scopus-id: 2-s2.0-85209914870
| 0 | 0 |
| 14 | Re-irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index | Coautor: Arrieta O., Gutierrez Torres S., Maldonado Magos F., Turcott J.G., et al. | 2023 | CANCER MEDICINE | WoS-id: 000818899900001
Scopus-id: 2-s2.0-85133065792
| 0 | 0 |
| 15 | LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer | Coautor: Arrieta O., Avilés-Salas A., Díaz-García D.A., Lara-Mejía L., et al. | 2023 | CURRENT ONCOLOGY | WoS-id: 000914551700001
Scopus-id: 2-s2.0-85146750085
| 3 | 3 |
| 16 | Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial | 1ᵉʳ autor: Arrieta O., Hernández-Pedro N., Maldonado F., Ramos-Ramírez M., et al. | 2023 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | WoS-id: 000991124100001
Scopus-id: 2-s2.0-85127328453
| 5 | 5 |
| 17 | Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country | Coautor: Arrieta O., Cifuentes C., Lombana M., Vargas H., et al. | 2023 | Cancer Control | WoS-id: 000992554400001
Scopus-id: 2-s2.0-85157987134
| 7 | 9 |
| 18 | Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer | Coautor: Arrieta O., São José C., Ferreira M., André A., et al. | 2023 | Gastric Cancer | WoS-id: 000999645000001
Scopus-id: 2-s2.0-85160585792
| 7 | 8 |
| 19 | Mortality Prognosis Factors in Patients with Active Cancer Under Treatment, and Severe COVID-19 | Coautor: Arrieta, Oscar, Cabrera-Galeana, Paula, Reynoso-Noveron, Nancy, Gonzalez-Nunez, Carlos, et al. | 2023 | Archives Of Medical Research | WoS-id: 001064664900001
Scopus-id: 2-s2.0-85167519780
| 1 | 1 |
| 20 | Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer | 1ᵉʳ autor: Arrieta O., Bolaño-Guerra L.M., Caballé-Pérez E., Lara-Mejía L., et al. | 2023 | Frontiers in Oncology | WoS-id: 001093403100001
Scopus-id: 2-s2.0-85175640623
| 4 | 4 |
| 21 | Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer | Coautor: Arrieta O., Hernández-Pedro N., Arroyo-Hernández M., Barrios-Bernal P., et al. | 2023 | Vaccines | WoS-id: 001095203200001
Scopus-id: 2-s2.0-85175343897
| 2 | 2 |
| 22 | Hacia la objetividad en la valoración ética: legibilidad como parte de la comprensión de los formatos de consentimiento informado | Coautor y autor de correspondencia: Arrieta O., Verástegui E., Páez R. | 2023 | GACETA MEDICA DE MEXICO | WoS-id: 001099808700009
Scopus-id: 2-s2.0-85178275018
| 0 | 0 |
| 23 | Mielolipoma primario mediastinal | Coautor: Arrieta O., Avilés-Salas A., Vélez-Valle A., Fernández-Vargas O.E. | 2023 | MEDICINA-BUENOS AIRES | WoS-id: 001109012900017
Scopus-id: 2-s2.0-85163644064
| 2 | 3 |
| 24 | PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma | Coautor: Arrieta O., Avilés-Salas A., Cabrera-Miranda L., Hernández-Pedro N., et al. | 2023 | Frontiers in Oncology | WoS-id: 001126533800001
Scopus-id: 2-s2.0-85180133236
| 5 | 4 |
| 25 | Carcinoma tipo-linfoepitelioma pulmonar con expresión de virus de Epstein-Barr y PD-L1 | Coautor: Arrieta O., Avilés-Salas A., Vélez-Valle A., Bryon-Gallego A. | 2023 | MEDICINA-BUENOS AIRES | Scopus-id: 2-s2.0-85153687305
| 0 | 0 |
| 26 | Obesity paradox and lung cancer, metformin-based therapeutic opportunity? | Coautor: Arrieta O., Barrios-Bernal P., Hernández-Pedro N., Lara-Mejía L. | 2023 | Oncotarget | Scopus-id: 2-s2.0-85164209671
| 0 | 2 |
| 27 | Towards objectivity in ethical assessment: legibility as part of informed consent form comprehension; | Coautor y autor de correspondencia: Arrieta O., Verástegui E., Páez R. | 2023 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-85179768451
| 0 | 1 |
| 28 | Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial | 1ᵉʳ autor: Arrieta O., Zatarain-Barrón Z.L., Turcott J.G., Barrón F., et al. | 2022 | JAMA oncology | WoS-id: 000742417500004
Scopus-id: 2-s2.0-85123024456
| 19 | 21 |
| 29 | Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and Nivolumab | Coautor: Arrieta O., Burgos R., Cardona A.F., Santoyo N., et al. | 2022 | Frontiers in Oncology | WoS-id: 000745730700001
Scopus-id: 2-s2.0-85123221804
| 7 | 5 |
| 30 | KRAS and MET in non-small-cell lung cancer: two of the new kids on the ?drivers? block | Coautor: Arrieta O., Garcia-Robledo J.E., Rosell R., Ruíz-Patiño A., et al. | 2022 | THER ADV RESPIR DIS | WoS-id: 000751857200001
Scopus-id: 2-s2.0-85123905646
| 15 | 19 |
| 31 | Appetite stimulants for patients with cancer: Current evidence for clinical practice | Coautor: Arrieta O., Turcott J.G., Zatarain-Barrón Z.L., Cárdenas Fernández D., et al. | 2022 | NUTRITION REVIEWS | WoS-id: 000766811400015
Scopus-id: 2-s2.0-85126152479
| 9 | 12 |
| 32 | Financial Toxicity Among Older Mexican Adults With Cancer and Their Families: A Mixed-Methods Study | Coautor: Arrieta, Oscar, Sanchez-Roman, Sofia, Chavarri-Guerra, Yanin, Vargas-Huicochea, Ingrid, et al. | 2022 | Jco Global Oncology | WoS-id: 000773789400008
Scopus-id: 2-s2.0-85126655693
| 18 | 22 |
| 33 | Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial-Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells | Coautor: Arrieta, Oscar, Barrios-Bernal, Pedro, Hernandez-Pedro, Norma, Orozco-Morales, Mario, et al. | 2022 | Pharmaceuticals | WoS-id: 000774458600001
Scopus-id: 2-s2.0-85127607758
| 11 | 15 |
| 34 | p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics | Coautor: Arrieta O., Ruiz-Patiño A., Rodríguez J., Cardona A.F., et al. | 2022 | TRANSLATIONAL ONCOLOGY | WoS-id: 000790037000006
Scopus-id: 2-s2.0-85119498132
| 13 | 13 |
| 35 | COVID-19 Vaccine Guidance for Patients with Cancer in Mexico: Report From the Working Group of the Mexican Society of Oncology | 2ᵒ autor: Arrieta O., Soto-Perez-de-Celis E., Bargalló-Rocha E., Campos-Gómez S., et al. | 2022 | Archives Of Medical Research | WoS-id: 000790218100014
Scopus-id: 2-s2.0-85112633707
| 2 | 2 |
| 36 | ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer | Coautor: Arrieta O., Passaro A., Leighl N., Blackhall F., et al. | 2022 | ANNALS OF ONCOLOGY | WoS-id: 000797900700004
Scopus-id: 2-s2.0-85127265519
| 160 | 174 |
| 37 | Classification of atypical EGFR mutations in non-small-cell lung cancer | Coautor: Arrieta O., Rosell R., Cardona A.F., González-Cao M. | 2022 | ANNALS OF ONCOLOGY | WoS-id: 000806396900002
Scopus-id: 2-s2.0-85127974198
| 1 | 1 |
| 38 | A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry | Coautor: Arrieta O., Whisenant J.G., Baena J., Cortellini A., et al. | 2022 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000808120800012
Scopus-id: 2-s2.0-85126335222
| 21 | 21 |
| 39 | Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question | Coautor: Arrieta O., Ordóñez-Reyes C., Garcia-Robledo J.E., Chamorro D.F., et al. | 2022 | Pharmaceutics | WoS-id: 000818175500001
Scopus-id: 2-s2.0-85132292554
| 28 | 31 |
| 40 | Challenges in Genetic Testing and Treatment Outcomes among Hispanics with Lung Cancer | Coautor: Arrieta O., Raez L.E., Cardona A.F., Lopes G. | 2022 | JCO Oncology Practice | WoS-id: 000819596200009
Scopus-id: 2-s2.0-85129966450
| 4 | 4 |
| 41 | Nuevas modalidades de interacción entre la industria farmacéutica y los médicos | 2ᵒ autor: Arrieta O., Domínguez J., Celis M.A., Islas S., et al. | 2022 | GACETA MEDICA DE MEXICO | WoS-id: 000823563000008
Scopus-id: 2-s2.0-85135377864
| 0 | 0 |
| 42 | Location of EGFR exon 20 insertions matters | Coautor: Arrieta O., Cardona A.F., González-Cao M., Rosell R. | 2022 | Cancer Cell | WoS-id: 000827824400004
Scopus-id: 2-s2.0-85133718287
| 0 | 0 |
| 43 | Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer | Coautor: Arrieta O., Nanjo S., Wu W., Karachaliou N., et al. | 2022 | JOURNAL OF CLINICAL INVESTIGATION | WoS-id: 000829089900003
Scopus-id: 2-s2.0-85133690141
| 51 | 50 |
| 44 | STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) | Coautor: Arrieta O., Cordeiro de Lima V.C., Corassa M., Saldanha E., et al. | 2022 | LUNG CANCER | WoS-id: 000829620600004
Scopus-id: 2-s2.0-85132705659
| 35 | 35 |
| 45 | Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses | Coautor: Arrieta, Oscar, Barrios-Bernal, Pedro, Zatarain-Barrón Z.L., Hernandez-Pedro, Norma, et al. | 2022 | Pharmaceuticals | WoS-id: 000831526200001
Scopus-id: 2-s2.0-85133477421
| 11 | 15 |
| 46 | Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial? | Coautor: Arrieta O., Remon J., Levy A., Singh P., et al. | 2022 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | WoS-id: 000834836600001
Scopus-id: 2-s2.0-85134959760
| 14 | 17 |
| 47 | Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors | Coautor: Arrieta O., Rojas L., Mayorga D., Ruiz-Patiño A., et al. | 2022 | ESMO Open | WoS-id: 000836446200001
Scopus-id: 2-s2.0-85132785142
| 7 | 9 |
| 48 | Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases | Coautor: Arrieta O., Cacho-Díaz B., Cuapantécatl L.D., Garcilazo-Reyes Y.J., et al. | 2022 | ONCOLOGY | WoS-id: 000844380200001
Scopus-id: 2-s2.0-85139571909
| 0 | 0 |
| 49 | Lung Cancer in Colombia | Coautor: Arrieta O., Cardona A.F., Mejía S.A., Viola L., et al. | 2022 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000863994300007
Scopus-id: 2-s2.0-85132872974
| 9 | 8 |
| 50 | Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP) | 2ᵒ autor: Arrieta O., Raez L.E., Chamorro D.F., Soberanis-Piña P.D., et al. | 2022 | Frontiers in Oncology | WoS-id: 000885753100001
Scopus-id: 2-s2.0-85135015966
| 10 | 10 |
| 51 | Recomendaciones de la Sociedad Mexicana de Oncología para la vacunación contra Covid-19 en personas con cáncer en México | 2ᵒ autor: Arrieta O., Soto-Pérez-de-Celis E., Bargalló-Rocha E., Campos-Gómez S., et al. | 2022 | SALUD PUBLICA DE MEXICO | WoS-id: 000894124400020
Scopus-id: 2-s2.0-85125872171
| 0 | 0 |
| 52 | Guía de Práctica Clínica para el diagnóstico temprano y la referencia oportuna del cáncer de pulmón | Coautor: Arrieta O., Arroyo-Hernández M., Alva-López L.F., Rendón A., et al. | 2022 | SALUD PUBLICA DE MEXICO | WoS-id: 000894131000019
Scopus-id: 2-s2.0-85137294876
| 2 | 3 |
| 53 | Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP) | Coautor: Arrieta O., Cardona A.F., Ruiz-Patiño A., Recondo G., et al. | 2022 | CLINICAL LUNG CANCER | WoS-id: 000898608200014
Scopus-id: 2-s2.0-85133607813
| 13 | 13 |
| 54 | Prognostic significance of telomerase reverse transcriptase promoter mutations in high grade meningiomas; | Coautor: Arrieta O., Cañas A., Jiménez E., Hakim F., et al. | 2022 | Biomedica | WoS-id: 000898827200003
Scopus-id: 2-s2.0-85137288068
| 1 | 1 |
| 55 | Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK -Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study | Coautor: Arrieta O., Solomon B.J., Bauer T.M., Ignatius Ou S.-H., et al. | 2022 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000924482600007
Scopus-id: 2-s2.0-85132508034
| 105 | 116 |
| 56 | The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations | Coautor: Arrieta O., Caglevic C., Rolfo C., Gil-Bazo I., et al. | 2022 | Jco Global Oncology | WoS-id: 000974926200033
Scopus-id: 2-s2.0-85136240090
| 37 | 45 |
| 57 | Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis | Coautor: Arrieta O., Bestvina C.M., Whisenant J.G., Torri V., et al. | 2022 | Jto Clinical And Research Reports | WoS-id: 001137481600004
Scopus-id: 2-s2.0-85134290270
| 15 | 15 |
| 58 | Brigatinib in ALK-positive non-small cell lung cancer: Real-world data in the Latin American population (Bri-world extend CLICaP) | Coautor: Arrieta O., Heredia D., Barrón F., Cardona A.F., et al. | 2021 | FUTURE ONCOL | WoS-id: 000573239800001
Scopus-id: 2-s2.0-85099833901
| 9 | 9 |
| 59 | LncRNA SOX2-OT regulates AKT/ERK and SOX2/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases | Coautor: Arrieta O., Herrera-Solorio A.M., Peralta-Arrieta I., Armas López L., et al. | 2021 | MOLECULAR ONCOLOGY | WoS-id: 000601604400001
Scopus-id: 2-s2.0-85097987812
| 41 | 46 |
| 60 | Radiation-induced lung injury: current evidence | Coautor: Arrieta O., Arroyo-Hernández M., Maldonado F., Lozano-Ruiz F., et al. | 2021 | BMC PULMONARY MEDICINE | WoS-id: 000608284200008
Scopus-id: 2-s2.0-85098875455
| 296 | 349 |
| 61 | Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study | Coautor: Arrieta O., Blake-Cerda M., Lozano-Ruíz F., Maldonado-Magos F., et al. | 2021 | LUNG CANCER | WoS-id: 000616364800018
Scopus-id: 2-s2.0-85098550476
| 27 | 30 |
| 62 | Genetic ancestry contributes to somatic mutations in lung cancers from admixed latin american populations | Coautor: Arrieta O., Carrot-Zhang J., Soca-Chafre G., Patterson N., et al. | 2021 | CANCER DISCOV | WoS-id: 000625890400023
Scopus-id: 2-s2.0-85102679378
| 116 | 111 |
| 63 | Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells | Coautor: Arrieta O., Cruz-Rico G., Avilés-Salas A., Popa-Navarro X., et al. | 2021 | PATHOLOGY & ONCOLOGY RESEARCH | WoS-id: 000641977100001
Scopus-id: 2-s2.0-85104593069
| 8 | 11 |
| 64 | Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease | 1ᵉʳ autor: Arrieta O., Salas A.A., Cardona A.F., Díaz-García D., et al. | 2021 | LUNG CANCER | WoS-id: 000644431500006
Scopus-id: 2-s2.0-85100541154
| 10 | 12 |
| 65 | Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort | Coautor: Arrieta O., Zatarain-Barrón Z.L., Cardona A.F., Diáz-Garciá D., et al. | 2021 | ONCOLOGY | WoS-id: 000645259600001
Scopus-id: 2-s2.0-85105163529
| 3 | 4 |
| 66 | Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma | 1ᵉʳ autor: Arrieta O., Muñoz-Montaño W., Muñiz-Hernández S., Campos S., et al. | 2021 | Frontiers in Oncology | WoS-id: 000646772200001
Scopus-id: 2-s2.0-85105311626
| 3 | 3 |
| 67 | Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab | Coautor: Arrieta O., Cardona A.F., Ruiz-Patiño A., Zatarain-Barron Z.L., et al. | 2021 | Case Reports in Oncology | WoS-id: 000648553000061
Scopus-id: 2-s2.0-85102595267
| 8 | 9 |
| 68 | Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case?control study | Coautor: Arrieta O., Muñoz-Montaño W.R., Cabrera-Galeana P., De la Garza-Ramos C., et al. | 2021 | BREAST CANCER RESEARCH AND TREATMENT | WoS-id: 000662143600001
Scopus-id: 2-s2.0-85108104009
| 9 | 12 |
| 69 | Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors | Coautor: Arrieta O., Orozco-Morales M., Avilés-Salas A., Hernández-Pedro N., et al. | 2021 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000665813500002
Scopus-id: 2-s2.0-85108553545
| 14 | 14 |
| 70 | Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial) | 1ᵉʳ autor: Arrieta O., Maldonado F., Turcott J.G., Zatarain-Barrón Z.L., et al. | 2021 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | WoS-id: 000680259900025
Scopus-id: 2-s2.0-85103432259
| 12 | 17 |
| 71 | Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities | Coautor: Arrieta O., Rosell R., Cardona A.F., Aguilar A., et al. | 2021 | BRITISH JOURNAL OF CANCER | WoS-id: 000683268400001
Scopus-id: 2-s2.0-85112619175
| 42 | 41 |
| 72 | RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin | Coautor: Arrieta O., Muñoz-Montaño W., Muñiz-Hernández S., Avilés-Salas A., et al. | 2021 | Bmc Cancer | WoS-id: 000684433800002
Scopus-id: 2-s2.0-85112660843
| 7 | 8 |
| 73 | Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies | 1ᵉʳ autor: Arrieta O., Lara-Mejía L., Bautista-GonzÁlez E., Heredia D., et al. | 2021 | Oncologist | WoS-id: 000695479600001
Scopus-id: 2-s2.0-85114636185
| 13 | 13 |
| 74 | Identification of a high-risk group for brain metastases in non-small cell lung cancer patients | Coautor: Arrieta O., Cacho-Díaz B., Cuapaténcatl L.D., Rodríguez J.A., et al. | 2021 | JOURNAL OF NEURO-ONCOLOGY | WoS-id: 000698071300001
Scopus-id: 2-s2.0-85115245858
| 10 | 11 |
| 75 | How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review | Coautor: Arrieta O., Torres G.F., Bonilla C.E., Buitrago G., et al. | 2021 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | WoS-id: 000701802700011
Scopus-id: 2-s2.0-85114020222
| 12 | 12 |
| 76 | Case-control study about magnitude of exposure to wood smoke and risk of developing lung cancer | Coautor: Arrieta, Oscar, Baez-Saldana, Renata, Canseco-Raymundo, Alejandro, Ixcot-Mejia, Belizario, et al. | 2021 | EUROPEAN JOURNAL OF CANCER PREVENTION | WoS-id: 000704209800007
Scopus-id: 2-s2.0-85117878497
| 9 | 10 |
| 77 | Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer | Coautor: Arrieta O., Malapelle U., Pisapia P., Addeo A., et al. | 2021 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | WoS-id: 000707822000001
Scopus-id: 2-s2.0-85117160357
| 33 | 33 |
| 78 | Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study | Coautor: Arrieta O., Maldonado F., Gonzalez-Ling A., Oñate-Ocaña L.F., et al. | 2021 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | WoS-id: 000709361500014
Scopus-id: 2-s2.0-85107669064
| 10 | 10 |
| 79 | A New Generation of Vaccines in the Age of Immunotherapy | Coautor: Arrieta O., Addeo A., Friedlaender A., Giovannetti E., et al. | 2021 | CURRENT ONCOLOGY REPORTS | WoS-id: 000714583600001
Scopus-id: 2-s2.0-85118718469
| 13 | 15 |
| 80 | Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean | Coautor: Arrieta O., Werutsky G., Barrios C.H., Cardona A.F., et al. | 2021 | LANCET ONCOLOGY | WoS-id: 000716464100007
Scopus-id: 2-s2.0-85118359776
| 24 | 30 |
| 81 | EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP) | Coautor: Arrieta O., Cardona A.F., Ordóñez-Reyes C., Ruiz-Patiño A., et al. | 2021 | JCO Precision Oncology | WoS-id: 000721836200012
Scopus-id: 2-s2.0-85117034013
| 6 | 7 |
| 82 | Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior | Coautor: Arrieta, Oscar, Rodriguez-Bautista, Ruben, Caro-Sanchez, Claudia H., Cabrera-Galeana, Paula, et al. | 2021 | Cancers | WoS-id: 000736246200001
Scopus-id: 2-s2.0-85121010304
| 15 | 14 |
| 83 | Impact of the covid-19 pandemic on oncology clinical research in latin america (lacog 0420) | Coautor: Arrieta O., Lara Gongora A.B., Werutsky G., Jardim D.L., et al. | 2021 | Jco Global Oncology | WoS-id: 000757074200005
Scopus-id: 2-s2.0-85105442085
| 15 | 16 |
| 84 | BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib | 2ᵒ autor: Arrieta O., Karachaliou N., Giménez-Capitán A., Aldeguer E., et al. | 2021 | Jto Clinical And Research Reports | WoS-id: 001136694200005
Scopus-id: 2-s2.0-85109887093
| 13 | 15 |
| 85 | Precision oncology in EGFR positive non-small cell lung cancer: Breaking the 10-year barrier-a case report | Coautor: Arrieta O., Ordóñez-Reyes C., Ruiz-Patiño A., Zatarain-Barrón L., et al. | 2021 | Precision Cancer Medicine | Scopus-id: 2-s2.0-85110737438
| 0 | 0 |
| 86 | Baseline Dysgeusia in Chemotherapy-Naïve Non-Small Cell Lung Cancer Patients: Association with Nutrition and Quality of Life | Coautor: Arrieta O., Turcott J.G., Juárez-Hernández E., Sánchez-Lara K., et al. | 2020 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | WoS-id: 000477103500001
Scopus-id: 2-s2.0-85068497147
| 14 | 15 |
| 87 | Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP) | 2ᵒ autor: Arrieta O., Ruiz-Patiño A., Cardona A.F., Martín C., et al. | 2020 | Thoracic Cancer | WoS-id: 000502076400001
Scopus-id: 2-s2.0-85076407068
| 52 | 50 |
| 88 | The importance of image guided radiotherapy in small cell lung cancer: Case report and review of literature | Coautor: Arrieta O., Lozano Ruiz F.J., Ileana Pérez Álvarez S., Poitevin Chacón M.A., et al. | 2020 | Reports of Practical Oncology and Radiotherapy | WoS-id: 000511162600026
Scopus-id: 2-s2.0-85077363748
| 9 | 9 |
| 89 | Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer | 1ᵉʳ autor: Arrieta O., Aviles-Salas A., Orozco-Morales M., Hernández-Pedro N., et al. | 2020 | CANCER MEDICINE | WoS-id: 000512453100001
Scopus-id: 2-s2.0-85079445127
| 59 | 61 |
| 90 | Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status | 1ᵉʳ autor: Arrieta O., Ramírez-Tirado L.-A., Caballé-Perez E., Mejia-Perez A., et al. | 2020 | Thoracic Cancer | WoS-id: 000514153700001
Scopus-id: 2-s2.0-85079895239
| 18 | 21 |
| 91 | Cancer-associated prothrombotic pathways: leucocytosis, but not thrombocytosis, correlates with venous thromboembolism in women with ovarian cancer | Coautor: Arrieta O., López-Salazar J., Ramírez-Tirado L.A., Gómez-Contreras N., et al. | 2020 | INTERNAL MEDICINE JOURNAL | WoS-id: 000518098400016
Scopus-id: 2-s2.0-85080940019
| 4 | 4 |
| 92 | Novel molecular targets for the treatment of lung cancer | Coautor y autor de correspondencia: Arrieta O., Rosell R., Karachaliou N. | 2020 | CURR OPIN ONCOL | WoS-id: 000524520800007
Scopus-id: 2-s2.0-85076065464
| 21 | 23 |
| 93 | Lung cancer in never smokers: The role of different risk factors other than tobacco smoking | Coautor: Arrieta O., Corrales L., Rosell R., Cardona A.F., et al. | 2020 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | WoS-id: 000527295500007
Scopus-id: 2-s2.0-85079121699
| 179 | 189 |
| 94 | Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab - Diagnostic and Therapeutic Challenge: A Case Report | Coautor: Arrieta O., Cardona A.F., Ruiz-Patiño A., Ricaurte L., et al. | 2020 | Case Reports in Oncology | WoS-id: 000533875000053
Scopus-id: 2-s2.0-85082519582
| 7 | 8 |
| 95 | Metformin Plus Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer-Reply | 1ᵉʳ autor: Arrieta O., Ramirez-Tirado L.A., Zatarain-Barrón Z.L. | 2020 | JAMA oncology | WoS-id: 000536236800022
Scopus-id: 2-s2.0-85081683339
| 1 | 1 |
| 96 | New opportunities in a challenging disease: lurbinectedin for relapsed small-cell lung cancer | 1ᵉʳ autor: Arrieta O., Zatarain-Barrón Z.L., Cardona A.F. | 2020 | LANCET ONCOLOGY | WoS-id: 000540084200023
Scopus-id: 2-s2.0-85083829827
| 4 | 4 |
| 97 | Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial | 1ᵉʳ autor: Arrieta O., Barrón F., Ramírez-Tirado L.A., Zatarain-Barrón Z.L., et al. | 2020 | JAMA oncology | WoS-id: 000542037700010
Scopus-id: 2-s2.0-85083206884
| 135 | 137 |
| 98 | Surgical care of thoracic malignancies during the COVID-19 pandemic in México: An expert consensus guideline from the Sociedad Mexicana de Oncología (SMeO) and the Sociedad Mexicana de Cirujanos Torácicos Generales (SMCTG) | Coautor: Arrieta O., Corona-Cruz J., Alba E.G.-D., Iñiguez-García M., et al. | 2020 | Thoracic Cancer | WoS-id: 000547600000001
Scopus-id: 2-s2.0-85087626912
| 2 | 4 |
| 99 | Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP) | Coautor: Arrieta O., Ruiz-Patiño A., Barrón F., Cardona A.F., et al. | 2020 | Thoracic Cancer | WoS-id: 000551478100001
Scopus-id: 2-s2.0-85088524670
| 17 | 17 |
| 100 | Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries | 2ᵒ autor: Arrieta O., Cardona A.F., Ruiz-Patiño A., Sotelo C., et al. | 2020 | THER ADV RESPIR DIS | WoS-id: 000551965800001
Scopus-id: 2-s2.0-85087711760
| 9 | 11 |
| 101 | Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy | Coautor: Arrieta O., Raez L.E., Cardona A.F., Lopes G. | 2020 | Jco Global Oncology | WoS-id: 000556801700003
Scopus-id: 2-s2.0-85086355459
| 25 | 24 |
| 102 | Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment | Coautor: Arrieta, Oscar, Munoz-Montano, Wendy, Cabrera-Galeana, Paula, Alvarado-Miranda, Alberto, et al. | 2020 | CLINICAL BREAST CANCER | WoS-id: 000558628300020
Scopus-id: 2-s2.0-85083301773
| 17 | 22 |
| 103 | Mortality and advanced support requirement for patients with cancer with COVID-19: A mathematical dynamic model for latin America | 2ᵒ autor: Arrieta O., Ruiz-Patiño A., Pino L.E., Rolfo C., et al. | 2020 | Jco Global Oncology | WoS-id: 000564860200007
Scopus-id: 2-s2.0-85085855057
| 8 | 8 |
| 104 | Carboplatin plus etoposide or topotecan for small-cell lung cancer | 1ᵉʳ autor: Arrieta O., Lara-Mejía L., Zatarain-Barrón Z.L. | 2020 | LANCET ONCOLOGY | WoS-id: 000568490900026
Scopus-id: 2-s2.0-85089940210
| 7 | 7 |
| 105 | Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations | 1ᵉʳ autor: Arrieta O., Catalán R., Guzmán-Vazquez S., Barrón F., et al. | 2020 | Bmc Cancer | WoS-id: 000569630300001
Scopus-id: 2-s2.0-85090180915
| 11 | 11 |
| 106 | Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group | 1ᵉʳ autor: Arrieta O., Cardona A.F., Lara-Mejía L., Heredia D., et al. | 2020 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | WoS-id: 000572848600008
Scopus-id: 2-s2.0-85087481311
| 15 | 18 |
| 107 | Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer | Coautor: Arrieta O., Rosell R., Karachaliou N., Fancelli S., et al. | 2020 | Translational Lung Cancer Research | WoS-id: 000573105400001
Scopus-id: 2-s2.0-85091696237
| 1 | 3 |
| 108 | Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma | 1ᵉʳ autor: Arrieta O., Lozano-Ruiz F., Blake-Cerda M., Catalán R., et al. | 2020 | Thoracic Cancer | WoS-id: 000575904700001
Scopus-id: 2-s2.0-85092201091
| 6 | 8 |
| 109 | CD47-SIRP alpha Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer | Coautor: Arrieta, Oscar, Catalan, Rodrigo, Orozco-Morales, Mario, Hernandez-Pedro, Norma Y., et al. | 2020 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000576132100003
Scopus-id: 2-s2.0-85092310330
| 37 | 36 |
| 110 | Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study) | Coautor: Arrieta O., Ruiz-Patiño A., Cardona A.F., Rolfo C., et al. | 2020 | JOURNAL OF CLINICAL EPIDEMIOLOGY | WoS-id: 000576195200001
Scopus-id: 2-s2.0-85087334646
| 7 | 6 |
| 111 | Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy | Coautor: Arrieta O., Barrón F., Sánchez R., Arroyo-Hernández M., et al. | 2020 | Frontiers in Oncology | WoS-id: 000578623200001
Scopus-id: 2-s2.0-85092536744
| 40 | 40 |
| 112 | Mentoring as an opportunity to improve research and cancer care in Latin America (AAZPIRE project) | Coautor: Arrieta O., Angel M.O., Colombo Bonadio R., Harada G., et al. | 2020 | ESMO Open | WoS-id: 000595917700002
Scopus-id: 2-s2.0-85096817692
| 8 | 6 |
| 113 | STRA6 Polymorphisms Are Associated With EGFR Mutations in Locally-Advanced and Metastatic Non-Small Cell Lung Cancer Patients | Coautor: Arrieta O., Muñiz-Hernández S., Velázquez-Fernández J.B., Díaz-Chávez J., et al. | 2020 | Frontiers in Oncology | WoS-id: 000596557100001
Scopus-id: 2-s2.0-85097414242
| 9 | 10 |
| 114 | Recomendaciones para la venta y promacion en el consultorio de tartamientos dermocosmeticos | Coautor: Arrieta O., Domínguez J., Verástegui E., Burgos R., et al. | 2020 | GACETA MEDICA DE MEXICO | WoS-id: 000596765100015
Scopus-id: 2-s2.0-85099290715
| 0 | 0 |
| 115 | Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL) | 2ᵒ autor: Arrieta O., Garcia-Campelo R., Massuti B., Rodriguez-Abreu D., et al. | 2020 | LUNG CANCER | WoS-id: 000598669100009
Scopus-id: 2-s2.0-85092676192
| 33 | 33 |
| 116 | Genotyping Squamous Cell Lung Carcinoma in Colombia (Geno1.1-CLICaP) | Coautor: Arrieta O., Cardona A.F., Ruiz-Patiño A., Ricaurte L., et al. | 2020 | Frontiers in Oncology | WoS-id: 000603377100001
Scopus-id: 2-s2.0-85098515273
| 5 | 5 |
| 117 | Overcoming TKI resistance in fusion-driven NSCLC: New generation inhibitors and rationale for combination strategies | Coautor: Arrieta O., Russo A., Cardona A.F., Caglevic C., et al. | 2020 | Translational Lung Cancer Research | WoS-id: 000607369400030
Scopus-id: 2-s2.0-85100089207
| 15 | 16 |
| 118 | Importancia del cuadro básico de medicamentos en la prescripción médica | Coautor: Arrieta O., Jasso L., Lifshitz A., Burgos R., et al. | 2020 | GACETA MEDICA DE MEXICO | WoS-id: 000662746100019
Scopus-id: 2-s2.0-85105692598
| 4 | 2 |
| 119 | Automedicación y autoprescripción | 2ᵒ autor: Arrieta O., Lifshitz A., Burgos R., Campillo C., et al. | 2020 | GACETA MEDICA DE MEXICO | WoS-id: 000662746100020
Scopus-id: 2-s2.0-85105692688
| 11 | 7 |
| 120 | La receta médica: ¿reflejo condicionado o reflexión consciente? | 2ᵒ autor: Arrieta O., Moreno M., Burgos R., Campillo C., et al. | 2020 | GACETA MEDICA DE MEXICO | WoS-id: 000662746100021
Scopus-id: 2-s2.0-85105693847
| 0 | 0 |
| 121 | A patient with newly diagnosed, advanced EGFR-mutated non?small cell lung cancer | Coautor: Arrieta-Rodríguez O., Lara-Mejía L., Sánchez-Reyes R., Avilés-Salas A. | 2020 | ONCOLOGY-NY | Scopus-id: 2-s2.0-85091595509
| 0 | 0 |
| 122 | Radical aggressive treatment among non-small cell lung cancer patients with malignant pleural effusion without extra-thoracic disease | 1ᵉʳ autor: Arrieta O., Escamilla-López I., Lyra-González I., Barrón F., et al. | 2019 | JOURNAL OF THORACIC DISEASE | WoS-id: 000459708900040
Scopus-id: 2-s2.0-85070393558
| 6 | 10 |
| 123 | Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP) | Coautor: Arrieta O., Rojas L., Cardona A.F., Trejo-Rosales R., et al. | 2019 | Thoracic Cancer | WoS-id: 000460181700013
Scopus-id: 2-s2.0-85060917696
| 10 | 10 |
| 124 | Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death | Coautor: Arrieta, Oscar, Beltrán-Anaya F.O., Romero-Cordoba, Sandra, Rebollar-Vega, Rosa, et al. | 2019 | MOLECULAR ONCOLOGY | WoS-id: 000462913100015
Scopus-id: 2-s2.0-85063622683
| 30 | 30 |
| 125 | Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study | 1ᵉʳ autor: Arrieta O., Barrón F., Maldonado F., Cabrera L., et al. | 2019 | LUNG CANCER | WoS-id: 000463276900010
Scopus-id: 2-s2.0-85061443801
| 49 | 48 |
| 126 | Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America | 1ᵉʳ autor: Arrieta O., Cardona A.F., Bramuglia G., Cruz-Rico G., et al. | 2019 | ONCOLOGY | WoS-id: 000463532200006
Scopus-id: 2-s2.0-85057746399
| 31 | 26 |
| 127 | Multigene mutation profiling and clinical characteristics of small-cell lung cancer in never-smokers vs. Heavy smokers (GENO1.3-clicap) | Coautor: Arrieta O., Cardona A.F., Rojas L., Zatarain-Barrón Z.L., et al. | 2019 | Frontiers in Oncology | WoS-id: 000464938900001
Scopus-id: 2-s2.0-85067444081
| 22 | 25 |
| 128 | FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients | Coautor: Arrieta O., Turcott J.G., Oñate-Ocaña L.F., Soca-Chafre G., et al. | 2019 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | WoS-id: 000465614600006
Scopus-id: 2-s2.0-85054359141
| 12 | 12 |
| 129 | Libertad de prescripción médica | 2ᵒ autor: Arrieta O., Lifshitz A., Campillo C., Burgos R., et al. | 2019 | GACETA MEDICA DE MEXICO | WoS-id: 000467013500015
Scopus-id: 2-s2.0-85065653071
| 3 | 3 |
| 130 | Respuesta a la carta al editor respecto al artículo ?El consentimiento informado: Recomendaciones para su documentación? | Coautor: Arrieta O., Celis M.Á., Sotelo J., Halabe J., et al. | 2019 | GACETA MEDICA DE MEXICO | WoS-id: 000467013500021
Scopus-id: 2-s2.0-85065646896
| 0 | 0 |
| 131 | Challenges and shifting paradigms in clinical trials in oncology: The case for immunological and targeted therapies | Coautor: Arrieta O., Sotelo-Rodríguez D.C., Ruíz-Patiño A., Ricaurte L., et al. | 2019 | ecancermedicalscience | WoS-id: 000474526200001
Scopus-id: 2-s2.0-85085971880
| 3 | 7 |
| 132 | Multiple Molecular Targets Associated with Genomic Instability in Lung Cancer | Coautor: Arrieta O., Soca-Chafre G., Montiel-Dávalos A., De La Rosa-Velázquez I.A., et al. | 2019 | INTERNATIONAL JOURNAL OF GENOMICS | WoS-id: 000475599600001
Scopus-id: 2-s2.0-85069052216
| 21 | 22 |
| 133 | Effect of complementary Integrative Oncology on anxiety, depression and quality of life in thoracic cancer patients: A pilot study | Coautor: Arrieta O., Menéndez-Aponte y Guzmán R.M., Turcott Chaparro J.G., De la Piedra Gómez A., et al. | 2019 | COMPLEMENT THER CLIN | WoS-id: 000478763500010
Scopus-id: 2-s2.0-85066246109
| 5 | 6 |
| 134 | Cáncer de pulmón. El peso de la enfermedad y avances en el diagnóstico y tratamiento | 1ᵉʳ autor: Arrieta O., Lazcano E. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351000001
Scopus-id: 2-s2.0-85067249746
| 11 | 10 |
| 135 | Lung cancer mortality and municipal marginalization in Mexico, 1998-2016 | Coautor: Arrieta O., Ramírez-Tirado L.A., Uribe-Ortiz C.E., Tirado-Gómez L.L. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800002
Scopus-id: 2-s2.0-85067263499
| 4 | 4 |
| 136 | Characteristics of non-small cell lung cancer: Differences by sex and hormonal status in a Mexican population | Coautor: Arrieta O., Rodríguez-Lara V., Ramírez-Tirado L.A., Barrón F., et al. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800004
Scopus-id: 2-s2.0-85067229525
| 12 | 12 |
| 137 | Tuberculosis and lung cancer | 2ᵒ autor: Arrieta O., Molina-Romero C., Hernández-Pando R. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800006
Scopus-id: 2-s2.0-85067244934
| 35 | 44 |
| 138 | Mutational profile by targeted next generation sequencing of non-small cell lung cancer in the Mexican population | Coautor: Arrieta O., Hernández-Pedro N., Soca-Chafre G., Alaez-Versón C., et al. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800009
Scopus-id: 2-s2.0-85067263481
| 17 | 16 |
| 139 | Squamous cell lung cancer: Genomic evolution and personalized therapy | Coautor: Arrieta O., Cardona A.F., Ricaurte L., Zatarain-Barrón Z.L. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800011
Scopus-id: 2-s2.0-85067233892
| 9 | 10 |
| 140 | Necesidades de cobertura y atención del cáncer pulmonar en México | Coautor: Arrieta O., Charvel S., Cobo-Armijo F., Hernández-ávila M., et al. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800012
Scopus-id: 2-s2.0-85067228144
| 6 | 6 |
| 141 | Access to lung cancer therapy in the Mexican population: Opportunities for reducing inequity within the health system | Coautor: Arrieta O., Gerson R., Zatarain-Barrón Z.L., Blanco C. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800014
Scopus-id: 2-s2.0-85067261054
| 20 | 19 |
| 142 | National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages | Coautor: Arrieta, Oscar, Barron-Barron, Feliciano, Guzman-De Aba, Enrique, Alatorre-Alexander, Jorge, et al. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000480351800015
Scopus-id: 2-s2.0-85069267979
| 69 | 25 |
| 143 | Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib | Coautor: Arrieta O., Cardona A.F., Ruiz-Patiño A., Zatarain-Barrón Z.L., et al. | 2019 | PLOS ONE | WoS-id: 000484893500009
Scopus-id: 2-s2.0-85067411149
| 23 | 29 |
| 144 | A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma | Coautor: Arrieta O., Cardona A.F., Rojas L., Wills B., et al. | 2019 | CLINICAL & TRANSLATIONAL ONCOLOGY | WoS-id: 000486535700010
Scopus-id: 2-s2.0-85062018458
| 10 | 10 |
| 145 | Lung Cancer in Mexico | 1ᵉʳ autor: Arrieta O., Zatarain-Barrón Z.L., Aldaco F., Barrón F., et al. | 2019 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000487254200021
Scopus-id: 2-s2.0-85072387534
| 18 | 16 |
| 146 | Association of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patients | Coautor: Arrieta O., Cacho-Díaz B., Spínola-Maroño H., Mendoza-Olivas L.G., et al. | 2019 | CLINICAL & TRANSLATIONAL ONCOLOGY | WoS-id: 000493999400012
Scopus-id: 2-s2.0-85071773899
| 10 | 11 |
| 147 | NGS-Molecular Characterization of Lung Adenocarcinomas from Hispanic Patients: Level of Evidence for Therapeutic Actionability | 1ᵉʳ autor: Arrieta, O., Gerson, R., Blanco, C., Alexander Meza, J., et al. | 2019 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000494945000076
| 0 | 0 |
| 148 | Cancer immunotherapy-associated hypophysitis | Coautor: Arrieta O., Castillero F., Castillo-Fernández O., Jiménez-Jiménez G., et al. | 2019 | FUTURE ONCOL | WoS-id: 000498635500007
Scopus-id: 2-s2.0-85072848719
| 22 | 28 |
| 149 | Conflictos de intereses en medicina. Recomendaciones del CETREMI | Coautor: Arrieta O., Celis M.Á., Halabe J., Burgos R., et al. | 2019 | GACETA MEDICA DE MEXICO | WoS-id: 000501793500018
Scopus-id: 2-s2.0-85074692461
| 1 | 1 |
| 150 | Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared with Tyrosine Kinase Inhibitors Alone in Patients with Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial | 1ᵉʳ autor: Arrieta O., Barrón F., Padilla M.-A.S., Avilés-Salas A., et al. | 2019 | JAMA oncology | WoS-id: 000509787900020
Scopus-id: 2-s2.0-85072117400
| 146 | 156 |
| 151 | Onco-omics approaches and applications in clinical trials for cancer patients | Coautor: Arrieta O., Hernandez-Martinez J.-M., Sánchez-Reyes R., De la Garza-Salazar J.G. | 2019 | Advances in Experimental Medicine and Biology | WoS-id: 000514075300006
Scopus-id: 2-s2.0-85074849593
| 4 | 5 |
| 152 | Importancia de la investigación clínica independiente en la medicina: Dificultades y recomendaciones | 1ᵉʳ autor: Arrieta O., Campillo C., Burgos R., Celis M.Á., et al. | 2019 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-85068492831
| 0 | 4 |
| 153 | Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR) | Coautor: Arrieta O., Ramos-Casals M., Maria A., Suárez-Almazor M.E., et al. | 2019 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | Scopus-id: 2-s2.0-85071636917
| 0 | 103 |
| 154 | Conflicts of interest in medicine. CETREMI recommendations | Coautor: Arrieta O., Celis M.Á., Halabe J., Burgos R., et al. | 2019 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-85079917752
| 0 | 2 |
| 155 | Suggestions about medications of proven effectiveness without commercial interest for the pharmaceutical industry | Coautor: Arrieta O., de la Llata M., Hálabe J., Plancarte R., et al. | 2019 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-85116868721
| 0 | 0 |
| 156 | Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma | Coautor: Arrieta O., Cardona A.F., Rojas L., Wills B., et al. | 2018 | JOURNAL OF NEURO-ONCOLOGY | WoS-id: 000422788000016
Scopus-id: 2-s2.0-85034849127
| 28 | 31 |
| 157 | Influence of estrogen in non-small cell lung cancer and its clinical implications | Coautor y autor de correspondencia: Arrieta O., Rodriguez-Lara V., Hernandez-Martinez J.-M. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000425262600102
Scopus-id: 2-s2.0-85041214343
| 90 | 96 |
| 158 | Response assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT in lung adenocarcinoma patients treated with nintedanib plus docetaxel | 1ᵉʳ autor: Arrieta O., Garcia-Perez F.O., Michel-Tello D., Ramírez-Tirado L.-A., et al. | 2018 | JOURNAL OF NUCLEAR MEDICINE | WoS-id: 000426474300032
Scopus-id: 2-s2.0-85044205650
| 6 | 5 |
| 159 | The reality of complexity: Concomitant genomic alterations in patients with EGFR mutations | Coautor: Arrieta O., Cardona A.F., Zatarain-Barrón Z.L., Rojas L. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000427737200037
Scopus-id: 2-s2.0-85042103794
| 2 | 2 |
| 160 | Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer | Coautor: Arrieta O., Torre-Bouscoulet L., Muñoz-Montaño W.R., Martínez-Briseño D., et al. | 2018 | RESPIRATORY RESEARCH | WoS-id: 000430762100003
Scopus-id: 2-s2.0-85045922551
| 48 | 57 |
| 161 | Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices | Coautor: Arrieta O., Martín C., Cardona A.F., Zatarain-Barrón Z.L., et al. | 2018 | ONCOLOGY | WoS-id: 000431100700006
Scopus-id: 2-s2.0-85046110113
| 12 | 12 |
| 162 | Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases | Coautor: Arrieta O., Vokes E.E., Ready N., Felip E., et al. | 2018 | ANNALS OF ONCOLOGY | WoS-id: 000431140700029
Scopus-id: 2-s2.0-85046647216
| 400 | 442 |
| 163 | The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments | Coautor: Arrieta O., Raez L.E., Cardona A.F., Santos E.S., et al. | 2018 | LUNG CANCER | WoS-id: 000431157800002
Scopus-id: 2-s2.0-85042470292
| 55 | 61 |
| 164 | Extending the curve: Survival of EGFR-mutated lung cancer patients in the 21st century | Coautor: Arrieta O., Barrón F., Zatarain-Barrón Z.L., Cardona A.F. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000431695300058
Scopus-id: 2-s2.0-85045271594
| 9 | 9 |
| 165 | Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation | Coautor: Arrieta O., Barrón F., Cardona A.F., Corrales L., et al. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000431699000027
Scopus-id: 2-s2.0-85046935764
| 17 | 15 |
| 166 | Myasthenia gravis as a prognostic marker in patients with thymoma | Coautor: Arrieta O., Cacho-Díaz B., Salmerón-Moreno K., Lorenzana-Mendoza N.A., et al. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000435834200057
Scopus-id: 2-s2.0-85048001324
| 12 | 11 |
| 167 | Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy | Coautor: Arrieta O., Cabrera-Galeana P., Muñoz-Montaño W., Lara-Medina F., et al. | 2018 | Oncologist | WoS-id: 000435952800011
Scopus-id: 2-s2.0-85042583730
| 63 | 65 |
| 168 | Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non-and triple-negative breast cancer | Coautor: Arrieta, Oscar, Rodriguez Bautista, Ruben, Ortega Gomez, Alette, Hidalgo Miranda, Alfredo, et al. | 2018 | Clinical Epigenetics | WoS-id: 000436625200003
Scopus-id: 2-s2.0-85049122239
| 53 | 57 |
| 169 | Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy | Coautor: Arrieta O., Torre-Bouscoulet L., Arroyo-Hernández M., Martínez-Briseño D., et al. | 2018 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | WoS-id: 000436809700027
Scopus-id: 2-s2.0-85048703260
| 15 | 15 |
| 170 | Extended resections of large thymomas: Importance of en bloc thymectomy | Coautor: Arrieta O., Corona-Cruz J.F., López-Saucedo R.A., Ramírez-Tirado L.A., et al. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000437096100058
Scopus-id: 2-s2.0-85049237211
| 5 | 7 |
| 171 | The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial | Coautor: Arrieta O., Turcott J.G., del Rocío Guillen Núñez M., Flores-Estrada D., et al. | 2018 | SUPPORTIVE CARE IN CANCER | WoS-id: 000440114100012
Scopus-id: 2-s2.0-85044041612
| 107 | 115 |
| 172 | Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer (vol 10, 88, 2018) | Coautor: Arrieta O., Bautista R.R., Gómez A.O., Miranda A.H., et al. | 2018 | Clinical Epigenetics | WoS-id: 000441220600001
Scopus-id: 2-s2.0-85051294413
| 10 | 12 |
| 173 | Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer | Coautor: Arrieta, Oscar, Barrera, Lourdes, Montes-Servin, Edgar, Hernandez-Martinez, Juan-Manuel, et al. | 2018 | CANCER IMMUNOLOGY IMMUNOTHERAPY | WoS-id: 000444138200007
Scopus-id: 2-s2.0-85049596093
| 45 | 52 |
| 174 | Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument | 1ᵉʳ autor: Arrieta O., Luvián-Morales J., Turcott J.G., Oñate-Ocaña L.F. | 2018 | QUALITY OF LIFE RESEARCH | WoS-id: 000444839000024
Scopus-id: 2-s2.0-85049696566
| 7 | 9 |
| 175 | Factors associated with long-term survival in central nervous system metastases | Coautor: Arrieta O., Cacho-Díaz B., Spínola-Maroño H., González-Aguilar A. | 2018 | JOURNAL OF NEURO-ONCOLOGY | WoS-id: 000446612400019
Scopus-id: 2-s2.0-85049803542
| 10 | 10 |
| 176 | EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) | Coautor: Arrieta O., Ruiz-Patiño A., Castro C.D., Ricaurte L.M., et al. | 2018 | TARGET ONCOL | WoS-id: 000446890500008
Scopus-id: 2-s2.0-85054579699
| 31 | 0 |
| 177 | Comprehensive review of fetal adenocarcinoma of the lung | 2ᵒ autor: Arrieta O., Ricaurte L.M., Zatarain-Barrón Z.L., Cardona A.F. | 2018 | Lung Cancer: Targets and Therapy | WoS-id: 000449668700001
Scopus-id: 2-s2.0-85059018115
| 15 | 31 |
| 178 | EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP) | Coautor: Arrieta O., Cardona A.F., Rojas L., Zatarain-Barrón Z.L., et al. | 2018 | LUNG CANCER | WoS-id: 000450378500038
Scopus-id: 2-s2.0-85054610184
| 55 | 59 |
| 179 | The importance of PD-L1 diagnostic assay harmonization for the selection of lung cancer immunotherapy | Coautor: Arrieta O., Hernandez-Martinez J.-M., Zatarain-Barron Z.L., Cardona A.F. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000451389400080
Scopus-id: 2-s2.0-85057428594
| 5 | 3 |
| 180 | Characteristics of Non-Small Cell Lung Cancer: Differences by Sex and Hormonal Status in a Hispanic Population | Coautor: Arrieta, O., Rodriguez-Lara, V., Ramirez-Tirado, L., Flores, D., et al. | 2018 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000454014502217
| 0 | 0 |
| 181 | Biodistribution and Tumor Uptake of Ga-67-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft | Coautor: Arrieta O., Izquierdo-Sánchez V., Muñiz-Hernández S., Vázquez-Becerra H., et al. | 2018 | Molecules | WoS-id: 000454523000088
Scopus-id: 2-s2.0-85057875142
| 4 | 5 |
| 182 | A novel biomarker protein panel for lung cancer, a promising first step | Coautor y autor de correspondencia: Arrieta O., Molina-Romero C., Vergara E. | 2018 | Translational Lung Cancer Research | WoS-id: 000454551800001
Scopus-id: 2-s2.0-85059558723
| 1 | 2 |
| 183 | Interplay between immune cells in lung cancer: Beyond T lymphocytes | Coautor: Arrieta O., Hernandez-Martinez J.-M., Vergara E., Montes-Servín E. | 2018 | Translational Lung Cancer Research | WoS-id: 000454551800009
Scopus-id: 2-s2.0-85100112899
| 1 | 1 |
| 184 | Leukocytosis, but Not Thrombocytosis, May Constitute a Prothrombotic Pathway in Women with Ovarian Cancer: A Cohort Study | Coautor: Arrieta, Oscar, Lopez Salazar, Javier, Ramirez Tirado, Laura A., Gomez Contreras, Nora, et al. | 2018 | Blood | WoS-id: 000454837603251
| 1 | 0 |
| 185 | Vista/PD-1H: A potential target for non-small cell lung cancer immunotherapy | Coautor: Arrieta O., Hernandez-Martinez J.-M., Vergara E., Zatarain-Barrón Z.L., et al. | 2018 | JOURNAL OF THORACIC DISEASE | WoS-id: 000456834700028
Scopus-id: 2-s2.0-85059503812
| 15 | 16 |
| 186 | Recomendaciones para la prescripción segura de opioides en el manejo del dolor crónico no oncológico | Coautor: Arrieta O., Verástegui E., Plancarte R., Domínguez J., et al. | 2018 | GACETA MEDICA DE MEXICO | WoS-id: 000462813400019
Scopus-id: 2-s2.0-85061588666
| 0 | 1 |
| 187 | Sugerencias en torno a medicamentos de efectividad demostrada sin interés comercial para la industria farmacéutica | Coautor: Arrieta O., de la Llata M., Hálabe J., Plancarte R., et al. | 2018 | GACETA MEDICA DE MEXICO | WoS-id: 000462813400020
Scopus-id: 2-s2.0-85061582401
| 0 | 0 |
| 188 | Recomendaciones a los cuerpos directivos de las agrupaciones médicas en su relación con la industria | Coautor: Arrieta O., Soda A., Campillo C., Burgos R., et al. | 2018 | GACETA MEDICA DE MEXICO | WoS-id: 000462813700015
Scopus-id: 2-s2.0-85056406989
| 1 | 1 |
| 189 | El consentimiento informado: recomendaciones para su documentación | Coautor: Arrieta O., Celis M.Á., Halabe J., Burgos R., et al. | 2018 | GACETA MEDICA DE MEXICO | WoS-id: 000462814300013
Scopus-id: 2-s2.0-85058607982
| 1 | 4 |
| 190 | Guía de Práctica Clínica Nacional para el tratamiento del cáncer de pulmón de células no pequeñas en estadios tempranos, localmente avanzados y metastásicos | Coautor: Arrieta-Rodríguez Ó.G., Barrón-Barrón F., Guzmán-De Alba E., Alatorre-Alexander J., et al. | 2018 | GACETA MEXICANA DE ONCOLOGIA | WoS-id: 000590303000004
Scopus-id: 2-s2.0-85063947459
| 0 | 0 |
| 191 | Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients | Coautor: Arrieta O., Soca-Chafre G., Hernández-Pedro N., Aviles-Salas A., et al. | 2018 | Oncotarget | Scopus-id: 2-s2.0-85050093640
| 0 | 8 |
| 192 | Positive tumor response to combined checkpoint inhibitors in a patient with refractory alveolar soft part sarcoma: A case report | Coautor: Arrieta O.G., Conley A.P., Trinh V.A., Zobniw C.M., et al. | 2018 | Journal Of Global Oncology | Scopus-id: 2-s2.0-85055270692
| 0 | 38 |
| 193 | Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer | Coautor: Arrieta, O., Avilés-Salas, A., Muñiz-Hernández, S., Maldonado-Martínez, H.A., et al. | 2017 | ONCOLOGY LETTERS | WoS-id: 000394927700054
Scopus-id: 2-s2.0-85007284225
| 24 | 25 |
| 194 | The use of electron microscopy for diagnosis of malignant pleural mesothelioma | 1ᵉʳ autor: Arrieta, O., Zatarain-Barron, Z.L., Carmona, A., Domínguez-Malagón, H. | 2017 | JOURNAL OF THORACIC DISEASE | WoS-id: 000398131900105
Scopus-id: 2-s2.0-85016501676
| 2 | 2 |
| 195 | What can doctors do to reduce health care costs? | Coautor: Arrieta Ó., Lifshitz A., Celis M.Á., Moreno M., et al. | 2017 | GACETA MEDICA DE MEXICO | WoS-id: 000400671500002
Scopus-id: 2-s2.0-85020423162
| 2 | 3 |
| 196 | Ramucirumab in the treatment of non-small cell lung cancer | 1ᵉʳ autor: Arrieta O., Zatarain-Barrón Z.L., Cardona A.F., Carmona A., et al. | 2017 | EXPERT OPINION ON DRUG SAFETY | WoS-id: 000400867200011
Scopus-id: 2-s2.0-85018825910
| 32 | 36 |
| 197 | CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients | Coautor: Arrieta O., Barrera L., Montes-Servín E., Hernandez-Martinez J.-M., et al. | 2017 | BRITISH JOURNAL OF CANCER | WoS-id: 000406207600013
Scopus-id: 2-s2.0-85029319732
| 89 | 88 |
| 198 | Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP) | 2ᵒ autor: Arrieta O., Cardona A.F., Zapata M.I., Rojas L., et al. | 2017 | TARGET ONCOL | WoS-id: 000406317200010
Scopus-id: 2-s2.0-85020865122
| 26 | 25 |
| 199 | Comparison of risk prediction scores for venous thromboembolism in cancer patients: A prospective cohort study | Coautor: Arrieta O., van Es N., Di Nisio M., Cesarman G., et al. | 2017 | HAEMATOLOGICA | WoS-id: 000408743300017
Scopus-id: 2-s2.0-85029592934
| 184 | 209 |
| 200 | The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy | Coautor: Arrieta, Oscar, Armas-Lopez, Leonel, Zuniga, Joaquin, Avila-Moreno, Federico | 2017 | Oncotarget | WoS-id: 000408944300054
Scopus-id: 2-s2.0-85028925184
| 46 | 52 |
| 201 | Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response | Coautor: Arrieta, Oscar, Marcela Herrera-Solorio, Abril, Armas-Lopez, Leonel, Zuniga, Joaquin, et al. | 2017 | Clinical Epigenetics | WoS-id: 000410373300001
Scopus-id: 2-s2.0-85028951011
| 28 | 34 |
| 202 | Epigenomic study identifies a novel mesenchyme homeobox 2-GLI1 transcription axis involved in cancer drug resistance overall survival and therapy prognosis in lung cancer patients | Coautor: Arrieta O., Armas-López L., Piña-Sánchez P., Alba E.G., et al. | 2017 | Oncotarget | WoS-id: 000410790500024
Scopus-id: 2-s2.0-85030484105
| 27 | 28 |
| 203 | Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in Lung adenocarcinoma subtypes | Coautor: Arrieta, Oscar, Molina-Romero, Camilo, Rangel-Escarenio, Claudia, Ortega-Gomez, Alette, et al. | 2017 | HUMAN PATHOLOGY | WoS-id: 000411911000023
Scopus-id: 2-s2.0-85028972501
| 11 | 12 |
| 204 | Lung Cancer Mortality in Mexico, 1990-2014 | Coautor y autor de correspondencia: Arrieta, Oscar, Tirado, Laura, Ramirez-Tirado, Laura-Alejandra | 2017 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000413055801079
| 0 | 0 |
| 205 | Differential Gene Expression of Lung Adenocarcinoma Histology Subtypes According to the IASLC/ATS/ERS Classification | 1ᵉʳ autor: Arrieta, Oscar, Molina Romero, Camilo, Rangel Escareno, Claudia, Ortega Gomez, Alette, et al. | 2017 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000413055802393
| 0 | 0 |
| 206 | An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP) | 2ᵒ autor: Arrieta O., Corrales-Rodríguez L., Mas L., Báez-Saldaña R., et al. | 2017 | LUNG CANCER | WoS-id: 000415777400006
Scopus-id: 2-s2.0-85029143929
| 28 | 32 |
| 207 | Survival outcomes according to TIMP1 and EGFR expression in heavily treated patients with advanced non-small cell lung cancer who received biweekly irinotecan plus bevacizumab | Coautor: Arrieta, O., Wills, B., Cardona, A.F., Rojas, L., et al. | 2017 | ANTICANCER RESEARCH | WoS-id: 000416143900061
Scopus-id: 2-s2.0-85032141626
| 10 | 12 |
| 208 | Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: Two-year outcomes from two randomized, open-label, phase III Trials (CheckMate 017 and CheckMate 057) | Coautor: Arrieta O., Horn L., Spigel D.R., Vokes E.E., et al. | 2017 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000417565500006
Scopus-id: 2-s2.0-85037986316
| 589 | 777 |
| 209 | Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer | Coautor: Arrieta O., Paz-Ares L.G., Pérol M., Ciuleanu T.-E., et al. | 2017 | LUNG CANCER | WoS-id: 000418728400018
Scopus-id: 2-s2.0-85027488928
| 17 | 20 |
| 210 | Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients | 1ᵉʳ autor: Arrieta O., Montes-Servín E., Hernandez-Martinez J.-M., Cardona A.F., et al. | 2017 | Oncotarget | WoS-id: 000419533200083
Scopus-id: 2-s2.0-85034817436
| 69 | 80 |
| 211 | Diagnosis of EML4 - ALK Translocation with FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients with Non-Small Cell Lung Cancer | Coautor: Arrieta O., Cruz-Rico G., Avilés-Salas A., Segura-González M., et al. | 2017 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | WoS-id: 000419719300016
Scopus-id: 2-s2.0-85036617362
| 23 | 23 |
| 212 | Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America | Coautor: Arrieta, O., Raez, L.E., Santos, E.S., Rolfo, C., et al. | 2017 | CLINICAL LUNG CANCER | WoS-id: 000504053200009
Scopus-id: 2-s2.0-85002736905
| 31 | 34 |
| 213 | Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer | Coautor: Arrieta O., Orozco-Morales M., Soca-Chafre G., Barrios-Bernal P., et al. | 2016 | MEDIATORS OF INFLAMMATION | WoS-id: 000369683900001
Scopus-id: 2-s2.0-84958213390
| 38 | 44 |
| 214 | In reply | Coautor: Arrieta O., De La Torre-Vallejo M., Turcott J., Baracos V. | 2016 | Oncologist | WoS-id: 000371073800002
Scopus-id: 2-s2.0-84957573844
| 2 | 2 |
| 215 | PET-Based Human Dosimetry of the Dimeric alpha(v)beta(3) Integrin Ligand Ga-68-DOTA-E-[c(RGDfK)](2), a Potential Tracer for Imaging Tumor Angiogenesis | Coautor: Arrieta, Oscar, Lopez-Rodriguez, Victoria, Galindo-Sarco, Carlos, Garcia-Perez, Francisco O., et al. | 2016 | JOURNAL OF NUCLEAR MEDICINE | WoS-id: 000371371800033
Scopus-id: 2-s2.0-84960088018
| 18 | 17 |
| 216 | Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy | Coautor: Arrieta O., Pérol M., Ciuleanu T.-E., Prabhash K., et al. | 2016 | LUNG CANCER | WoS-id: 000371838700015
Scopus-id: 2-s2.0-84959441334
| 36 | 42 |
| 217 | Proposals for the prevention of lung cancer in the health system of Mexico | 1ᵉʳ autor: Arrieta O., López-Mejía M., Macedo-Pérez E.O., Corona-Cruz J.F. | 2016 | SALUD PUBLICA DE MEXICO | WoS-id: 000372689500020
Scopus-id: 2-s2.0-84970005917
| 13 | 14 |
| 218 | Changes in the Detection and Recognition Thresholds of Three Basic Tastes in Lung Cancer Patients Receiving Cisplatin and Paclitaxel and Its Association with Nutritional and Quality of Life Parameters | Coautor: Arrieta, Oscar, Turcott, Jenny G., Juarez-Hernandez, Eva, De la Torre-Vallejo, Martha, et al. | 2016 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | WoS-id: 000373285300009
Scopus-id: 2-s2.0-84962662242
| 32 | 34 |
| 219 | Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure | Coautor: Arrieta O., Ortega-Gómez A., Rangel-Escareño C., Molina-Romero C., et al. | 2016 | RESPIRATORY RESEARCH | WoS-id: 000374677000001
Scopus-id: 2-s2.0-84963851435
| 16 | 18 |
| 220 | Pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab in Hispanic patients with non-squamous non-small cell lung cancer: Outcomes according to thymidylate synthase expression | Coautor: Arrieta O., Cardona A.F., Rojas L., Wills B., et al. | 2016 | PLOS ONE | WoS-id: 000376286100015
Scopus-id: 2-s2.0-84971264245
| 9 | 10 |
| 221 | Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study | Coautor: Arrieta O., Cadranel J., Park K., Pless M., et al. | 2016 | LUNG CANCER | WoS-id: 000380596400002
Scopus-id: 2-s2.0-84969222299
| 22 | 27 |
| 222 | Epithelial?mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy | Coautor: Arrieta O., Rojas-Puentes L., Cardona A.F., Carranza H., et al. | 2016 | CANCER MEDICINE | WoS-id: 000380926600028
Scopus-id: 2-s2.0-85027922062
| 28 | 35 |
| 223 | Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer | 1ᵉʳ autor: Arrieta, O., Varela-Santoyo, E., Soto-Perez-de-Celis, E., Sánchez-Reyes, R., et al. | 2016 | Bmc Cancer | WoS-id: 000384181800001
Scopus-id: 2-s2.0-84988346190
| 45 | 51 |
| 224 | Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma | Coautor: Arrieta, O., DomÃnguez-Malagón, H., Cano-Valdez, A.M., González-Carrillo, C., et al. | 2016 | ULTRASTRUCTURAL PATHOLOGY | WoS-id: 000384694300004
Scopus-id: 2-s2.0-84978039235
| 8 | 7 |
| 225 | Skin communicates what we deeply feel: Antibiotic prophylactic treatment to reduce epidermal growth factor receptor inhibitors induced rash in lung cancer (the Pan Canadian rash trial) | 1ᵉʳ autor: Arrieta O., Carmona A., de Jesus Vega M.T., Lopez-Mejia M., et al. | 2016 | Annals of Translational Medicine | WoS-id: 000384793500015
Scopus-id: 2-s2.0-85006200780
| 1 | 1 |
| 226 | Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial | 1ᵉʳ autor: Arrieta O., Cruz-Rico G., Soto-Perez-de-Celis E., Ramírez-Tirado L.-A., et al. | 2016 | TARGET ONCOL | WoS-id: 000385199400005
Scopus-id: 2-s2.0-84962197460
| 15 | 15 |
| 227 | Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials | 1ᵉʳ autor: Arrieta, O., Carmona, A., Ramírez-Tirado, L.A., Flores-Estrada, D., et al. | 2016 | ONCOLOGY | WoS-id: 000385910300003
Scopus-id: 2-s2.0-84980340076
| 20 | 22 |
| 228 | The safety of afatinib for the treatment of non-small cell lung cancer | Coautor: Arrieta, O., Barron, F., de la Torre-Vallejo, M., Luna-Palencia, R.L., et al. | 2016 | EXPERT OPINION ON DRUG SAFETY | WoS-id: 000386677500013
Scopus-id: 2-s2.0-84988912301
| 16 | 19 |
| 229 | BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations | Coautor: Arrieta O., Cardona A.F., Rojas L., Wills B., et al. | 2016 | Oncotarget | WoS-id: 000387446800095
Scopus-id: 2-s2.0-85020899428
| 28 | 31 |
| 230 | Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer | Coautor: Arrieta, O., Muñiz-Hernández, S., Huerta-Yepez, S., Hernández-Pedro, N., et al. | 2016 | INT J CLIN ONCOL | WoS-id: 000389202200005
Scopus-id: 2-s2.0-84974849302
| 9 | 9 |
| 231 | 192TiP: NEPTUNE: A global, phase 3 study of durvalumab (MEDI4736) plus tremelimumab combination therapy versus standard of care (SoC) platinum-based chemotherapy in the first-line treatment of patients (pts) with advanced or metastatic NSCLC | Coautor: Arrieta O., Mok T., Schmid P., Arén O., et al. | 2016 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000412866300187
Scopus-id: 2-s2.0-85017731911
| 30 | 35 |
| 232 | Genotyping low-grade gliomas among hispanics | Coautor: Arrieta O., Cardona A.F., Rojas L., Wills B., et al. | 2016 | Neuro-Oncology Practice | Scopus-id: 2-s2.0-85034620066
| 0 | 7 |
| 233 | Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer | Coautor: Arrieta O., Macedo-Pérez E.O., Morales-Oyarvide V., Mendoza-García V.O., et al. | 2015 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | WoS-id: 000342419600004
Scopus-id: 2-s2.0-84925546987
| 15 | 15 |
| 234 | KRAS mutation as the biomarker of response to chemotherapy and EGFR-TKIs in patients with advanced non-small cell lung cancer: Clues for its potential use in second-line therapy decision making | Coautor: Arrieta O., Campos-Parra A.D., Zuloaga C., Manríquez M.E.V., et al. | 2015 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | WoS-id: 000348288900007
Scopus-id: 2-s2.0-84964264802
| 28 | 38 |
| 235 | Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of Mexico | 1ᵉʳ autor: Arrieta O., Quintana-Carrillo R.H., Ahumada-Curiel G., Corona-Cruz J.F., et al. | 2015 | TOBACCO INDUCED DISEASES | WoS-id: 000348937700001
Scopus-id: 2-s2.0-84924127514
| 23 | 28 |
| 236 | Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis | Coautor: Arrieta O'., Barrera L., Montes-Servín E., Barrera A., et al. | 2015 | ANNALS OF ONCOLOGY | WoS-id: 000349609600026
Scopus-id: 2-s2.0-84925341188
| 66 | 69 |
| 237 | The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer | 1ᵉʳ autor: Arrieta O., Cardona A.F., Corrales L., Campos-Parra A.D., et al. | 2015 | LUNG CANCER | WoS-id: 000350528500013
Scopus-id: 2-s2.0-84922466166
| 75 | 87 |
| 238 | Updated frequency of EGFR and KRAS mutations in NonSmall-cell lung cancer in Latin America: The Latin-American consortium for the investigation of lung cancer (CLICaP) | 1ᵉʳ autor: Arrieta O., Cardona A.F., Martín C., Más-López L., et al. | 2015 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000354990100027
Scopus-id: 2-s2.0-84938287765
| 167 | 174 |
| 239 | Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma | Coautor: Arrieta O., Ruiz-Morales J.M., Dorantes-Heredia R., Chávez-Tapia N.C., et al. | 2015 | TUMOR BIOLOGY | WoS-id: 000355199800055
Scopus-id: 2-s2.0-84929962353
| 27 | 27 |
| 240 | Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients | 1ᵉʳ autor: Arrieta O., Vega-González M.T., López-Macías D., Martínez-Hernández J.N., et al. | 2015 | LUNG CANCER | WoS-id: 000355711900007
Scopus-id: 2-s2.0-84929518630
| 57 | 58 |
| 241 | Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer | 1ᵉʳ autor: Arrieta O., Villarreal-Garza C., Vizcaíno G., Pineda B., et al. | 2015 | TUMOR BIOLOGY | WoS-id: 000359569000091
Scopus-id: 2-s2.0-84938213886
| 56 | 60 |
| 242 | Nutritional status, body surface, and low lean body mass/body mass index are related to dose reduction and severe gastrointestinal toxicity induced by afatinib in patients with non-small cell lung cancer | 1ᵉʳ autor: Arrieta O., de la Torre-Vallejo M., López-Macias D., Orta D., et al. | 2015 | Oncologist | WoS-id: 000360973500022
Scopus-id: 2-s2.0-84940022374
| 75 | 82 |
| 243 | Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer | Coautor: Arrieta O., Borghaei H., Paz-Ares L., Horn L., et al. | 2015 | NEW ENGLAND JOURNAL OF MEDICINE | WoS-id: 000363317800008
Scopus-id: 2-s2.0-84944937210
| 8022 | 8603 |
| 244 | Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox" | 1ᵉʳ autor: Arrieta O., Ramírez-Tirado L.-A., Báez-Saldaña R., Peña-Curiel O., et al. | 2015 | LUNG CANCER | WoS-id: 000364882500007
Scopus-id: 2-s2.0-84955304728
| 51 | 52 |
| 245 | Editorial | Coautor: Arrieta Ó., Kershenobich D., Ruiz-Palacios G., Ulloa-Aguirre A., et al. | 2015 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000368650400001
Scopus-id: 2-s2.0-85040609480
| 0 | 0 |
| 246 | A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma | 1ᵉʳ autor: Arrieta O., López-Macías D., Mendoza-Garcia, VO, Bacon-Fonseca L., et al. | 2014 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | WoS-id: 000335391500012
Scopus-id: 2-s2.0-84900806751
| 27 | 29 |
| 247 | Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease | Coautor: Arrieta O., Campos-Parra A.D., Avilés A., Contreras-Reyes S., et al. | 2014 | EUROPEAN RESPIRATORY JOURNAL | WoS-id: 000335614600029
Scopus-id: 2-s2.0-84899850134
| 52 | 60 |
| 248 | Retinoic acid reduces solvent-induced neuropathy and promotes neural regeneration in mice | Coautor: Arrieta O., Palencia G., Hernández-Pedro N., Saavedra-Perez D., et al. | 2014 | JOURNAL OF NEUROSCIENCE RESEARCH | WoS-id: 000337621900012
Scopus-id: 2-s2.0-84902551331
| 5 | 6 |
| 249 | Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients | 1ᵉʳ autor: Arrieta O., Pineda B., Muniz-Hernandez, S, Flores D., et al. | 2014 | CANCER BIOMARKERS | WoS-id: 000337916100004
Scopus-id: 2-s2.0-84908175902
| 13 | 15 |
| 250 | High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin | 1ᵉʳ autor: Arrieta O., Medina, LA, Estrada-Lobato E., Ramirez-Tirado, LA, et al. | 2014 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | WoS-id: 000338759700021
Scopus-id: 2-s2.0-84903818206
| 45 | 50 |
| 251 | Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer | 1ᵉʳ autor: Arrieta O., Blake M., De La Mata-Moya M.D., Corona F., et al. | 2014 | RADIOTHER ONCOL | WoS-id: 000339150100024
Scopus-id: 2-s2.0-84902548841
| 40 | 45 |
| 252 | Science and confidence: The need to be clear - Response [Ciencia y confianza: La necesidad de ser claros - Respuesta] | 1ᵉʳ autor y autor de correspondencia: Arrieta O. | 2014 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000339933100015
Scopus-id: 2-s2.0-84901008569
| 0 | 0 |
| 253 | Vitamin A increases nerve growth factor and retinoic acid receptor beta and improves diabetic neuropathy in rats | Coautor: Arrieta O., Hernández-Pedro N., Granados-Soto V., Ordonez, G, et al. | 2014 | TRANSL RES | WoS-id: 000340738200003
Scopus-id: 2-s2.0-84907738436
| 18 | 20 |
| 254 | Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial | Coautor: Arrieta O., Garon E.B., Ciuleanu, TE, Prabhash K., et al. | 2014 | Lancet | WoS-id: 000341359100024
Scopus-id: 2-s2.0-84906903314
| 1094 | 1218 |
| 255 | Variability of apparent diffusion coefficients in metastatic small cell lung carcinoma: comparisons between-within normal tissue and liver metastases | Coautor: Arrieta O., Roldán-Valadez E., Cortez-Conradis D., Ríos-Hoyo A. | 2014 | Annals Of Hepatology | WoS-id: 000341467100018
Scopus-id: 2-s2.0-84893654853
| 2 | 3 |
| 256 | Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: Randomised trial | Coautor: Arrieta O., Sánchez-Lara K., Turcott J.G., Juárez-Hernández E., et al. | 2014 | CLINICAL NUTRITION | WoS-id: 000347362400013
Scopus-id: 2-s2.0-84920145764
| 192 | 208 |
| 257 | Aggressive treatment of primary tumor in patients with non-small-cell lung cancer and exclusively brain metastases | Coautor: Arrieta O., Villarreal-Garza C., De La Mata D., Zavala D.G., et al. | 2013 | CLINICAL LUNG CANCER | WoS-id: 000313059700002
Scopus-id: 2-s2.0-84871579055
| 32 | 36 |
| 258 | Alternating chemotherapy: Gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer | Coautor: Arrieta O., Aguilar-Ponce J.L., Granados-García M., Lopez, JCC, et al. | 2013 | ORAL ONCOLOGY | WoS-id: 000314871900016
Scopus-id: 2-s2.0-84873408095
| 8 | 10 |
| 259 | Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer | 1ᵉʳ autor: Arrieta O., Angulo L.P., Nunez-Valencia, C, Dorantes-Gallareta Y., et al. | 2013 | ANNALS OF SURGICAL ONCOLOGY | WoS-id: 000319169100027
Scopus-id: 2-s2.0-84878222806
| 276 | 293 |
| 260 | Usefulness of Serum Carcinoembryonic Antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: A prospective cohort study | 1ᵉʳ autor: Arrieta O., Villarreal-Garza C., Martínez-Barrera L., Morales M., et al. | 2013 | Bmc Cancer | WoS-id: 000319663800001
Scopus-id: 2-s2.0-84878006279
| 57 | 65 |
| 261 | Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases | Coautor: Arrieta O., Rojas-Puentes L.L., Gonzalez-Pinedo M., Crismatt A., et al. | 2013 | RADIAT ONCOL | WoS-id: 000324861600001
Scopus-id: 2-s2.0-84883540292
| 114 | 123 |
| 262 | Consenso nacional de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas | 1ᵉʳ autor: Arrieta O., Guzmán-de Alba E., Alba-López L.F., Acosta-Espinoza A., et al. | 2013 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000339932800001
Scopus-id: 2-s2.0-84886876615
| 63 | 64 |
| 263 | Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin | Coautor: Arrieta O., Orozco-Morales M., Sanchez-Garcia, FJ, Guevara-Salazar P., et al. | 2012 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | WoS-id: 000300344500003
Scopus-id: 2-s2.0-84857064068
| 15 | 15 |
| 264 | Clinical Features and Prognostic Factors in Patients with Carcinomatous Meningitis Secondary to Breast Cancer | Coautor: Arrieta O., Lara-Medina F., Crismatt A., Villarreal-Garza C., et al. | 2012 | BREAST J | WoS-id: 000304002000006
Scopus-id: 2-s2.0-84861201849
| 43 | 53 |
| 265 | Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-C | Coautor: Arrieta O., Sánchez-Lara K., Turcott J.G., Juárez E., et al. | 2012 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | WoS-id: 000304327700006
Scopus-id: 2-s2.0-84861442854
| 127 | 136 |
| 266 | Clinical and Pathological Characteristics, Outcome and Mutational Profiles Regarding Non-Small-Cell Lung Cancer Related to Wood-Smoke Exposure | 1ᵉʳ autor: Arrieta O., Campos-Parra A.D., Zuloaga C., Avilés A., et al. | 2012 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000306459000009
Scopus-id: 2-s2.0-84863856184
| 55 | 60 |
| 267 | Lung metastasectomy: Long-term outcomes in an 18-year cohort from a single center | Coautor: Arrieta O., Corona-Cruz J.F., Domínguez-Parra L.M., Saavedra-Pérez D., et al. | 2012 | SURGICAL ONCOLOGY-OXFORD | WoS-id: 000308123600019
Scopus-id: 2-s2.0-84864658942
| 9 | 16 |
| 268 | Personalized treatment in non-small cell lung cancer [Personalización del tratamiento del cáncer de pulmón de células no pequeñas] | Coautor y autor de correspondencia: Arrieta Ó., Campos-Parra A.D., Cruz-Rico G. | 2012 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000311258700008
Scopus-id: 2-s2.0-84869793446
| 7 | 9 |
| 269 | Genotyping non-small cell lung cancer (NSCLC) [Genotipificación en cáncer de pulmón de células no pequeñas] | Coautor y autor de correspondencia: Arrieta O., Campos-Parra A.D., Cruz-Rico G. | 2012 | GACETA MEXICANA DE ONCOLOGIA | Scopus-id: 2-s2.0-84891782779
| 0 | 1 |
| 270 | High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following | 1ᵉʳ autor: Arrieta O., Villarreal-Garza C., Pachuca D., Ortega, RMM, et al. | 2011 | MEDICAL ONCOLOGY | WoS-id: 000287756000049
Scopus-id: 2-s2.0-79952249569
| 11 | 13 |
| 271 | Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial | 2ᵒ autor: Arrieta, Oscar, de Boer, Richard H., Yang, Chih-Hsin, Gottfried, Maya, et al. | 2011 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000288161000032
Scopus-id: 2-s2.0-79952742483
| 232 | 253 |
| 272 | Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer | Coautor: Arrieta, Oscar, Hirsh, Vera, Paz-Ares, Luis, Boyer, Michael, et al. | 2011 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000292210500019
Scopus-id: 2-s2.0-79960110662
| 125 | 132 |
| 273 | Triple-negative breast cancer in Hispanic patients: High prevalence, poor prognosis, and association with menopausal status, body mass index, and parity | Coautor: Arrieta, O, Lara-Medina, F, Perez-Sanchez, V, Saavedra-Perez, D, et al. | 2011 | CANCER | WoS-id: 000293672700006
Scopus-id: 2-s2.0-80051518997
| 175 | 187 |
| 274 | Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer | 1ᵉʳ autor: Arrieta, O, Hernandez-Pedro, N, Fernandez-Gonzalez-Aragon, MC, Saavedra-Perez, D, et al. | 2011 | Neurology | WoS-id: 000294538100018
Scopus-id: 2-s2.0-80055100625
| 58 | 61 |
| 275 | Long-term Survival in Patients with Non-small Cell Lung Cancer and Synchronous Brain Metastasis Treated with Whole-brain Radiotherapy and Thoracic Chemo-radiation | 2ᵒ autor: Arrieta, O, De La Mata, M, Blake-Cerda, M, Villareal-Garza, C, et al. | 2011 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | WoS-id: 000296411701324
| 0 | 0 |
| 276 | Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America | 1ᵉʳ autor: Arrieta O., Cardona A.F., Bramuglia, GF, Gallo A., et al. | 2011 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000296700400025
Scopus-id: 2-s2.0-80054948914
| 93 | 100 |
| 277 | Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation | 1ᵉʳ autor: Arrieta O., Villarreal-Garza C., Zamora J., Blake-Cerda M., et al. | 2011 | RADIAT ONCOL | WoS-id: 000297935200001
Scopus-id: 2-s2.0-82055181808
| 94 | 99 |
| 278 | Effectiveness and prognosis of initial pericardiocentesis in the primary management of malignant pericardial effusion | Coautor: Arrietab O., Apodaca-Cruza Á., Villarreal-Garzab C., Torres-Ávila B., et al. | 2010 | INTERACT CARDIOV TH | WoS-id: 000208482300007
Scopus-id: 2-s2.0-77957333219
| 30 | 33 |
| 279 | Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study | 1ᵉʳ autor: Arrieta O., Ortega, RMM, Villanueva-Rodríguez G., Serna-Thomé M.G., et al. | 2010 | Bmc Cancer | WoS-id: 000275794800002
Scopus-id: 2-s2.0-77649293757
| 236 | 260 |
| 280 | Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy | Coautor: Arrieta O., Sanchez-Lara, K, Sosa-Snchez R., Green-Renner D., et al. | 2010 | NUTRITION JOURNAL | WoS-id: 000277142900001
Scopus-id: 2-s2.0-77951599176
| 105 | 109 |
| 281 | Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value | Coautor: Arrieta O., Garcia-Navarrete R., Garcia E., Sotelo J. | 2010 | JOURNAL OF NEURO-ONCOLOGY | WoS-id: 000278349200004
Scopus-id: 2-s2.0-77953287543
| 18 | 19 |
| 282 | Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma | Coautor: Arrieta O., Guevara P., Escobar-Arriaga E., Saavedra-Perez D., et al. | 2010 | JOURNAL OF NEURO-ONCOLOGY | WoS-id: 000278687900011
Scopus-id: 2-s2.0-77953619087
| 51 | 55 |
| 283 | Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non-Small-Cell Lung Cancer | 1ᵉʳ autor: Arrieta O., González-De La Rosa C.H., Aréchaga-Ocampo E., Villanueva-Rodríguez G., et al. | 2010 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000280003700011
Scopus-id: 2-s2.0-77955296228
| 113 | 124 |
| 284 | Methylenetetrahydrofolate Reductase Polymorphism (677 C > T) Predicts Long Time to Progression in Metastatic Colon Cancer Treated with 5-Fluorouracil and Folinic Acid | Coautor: Arrieta O., Castillo-Fernández O., Santibanez, M, Bauza A., et al. | 2010 | Archives Of Medical Research | WoS-id: 000284678700005
Scopus-id: 2-s2.0-78049442304
| 17 | 24 |
| 285 | Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis | 1ᵉʳ autor: Arrieta O., Saavedra-Perez D., Kuri R., Aviles-Salas A., et al. | 2009 | Bmc Cancer | WoS-id: 000266726800002
Scopus-id: 2-s2.0-65649120776
| 128 | 143 |
| 286 | High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine after Induction with Ge | 1ᵉʳ autor: Arrieta O., Gallardo-Rincon, D, Villarreal-Garza, C, Michel R.M., et al. | 2009 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000267386000013
Scopus-id: 2-s2.0-68349116963
| 64 | 66 |
| 287 | Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-Treated Nonsmall Cell Lung Cancer Patients | 1ᵉʳ autor: Arrieta, O, Trejo, MAR, Michel, RM | 2009 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000268541000024
Scopus-id: 2-s2.0-68349088963
| 5 | 5 |
| 288 | Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer | 2ᵒ autor: Arrieta O., Alvarado-Miranda A., Gamboa-Vignolle C., Saavedra-Perez D., et al. | 2009 | RADIAT ONCOL | WoS-id: 000269304900001
Scopus-id: 2-s2.0-68349107811
| 28 | 39 |
| 289 | Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors | 1ᵉʳ autor: Arrieta O., Ortega, RMM, Ángeles-Snchez J., Villarreal-Garza C., et al. | 2009 | J EXP CLIN CANC RES | WoS-id: 000269834800001
Scopus-id: 2-s2.0-70349308677
| 22 | 26 |
| 290 | Female gender but not cigarette smoking delays the onset of Parkinson's disease | 2ᵒ autor: Arrieta O., Martínez-Rumayor A., Sotelo J., García E. | 2009 | CLINICAL NEUROLOGY AND NEUROSURGERY | WoS-id: 000271446700005
Scopus-id: 2-s2.0-70349630679
| 8 | 13 |
| 291 | Radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin | Coautor: Arrieta, O, Michel, RM, Gallardo-Rincon, D, Villarreal-Garza, C, et al. | 2009 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000276606605201
| 0 | 0 |
| 292 | Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis | 1ᵉʳ autor: Arrieta O., Pineda-Olvera B., Guevara-Salazar P., Hernández-Pedro N., et al. | 2008 | BRITISH JOURNAL OF CANCER | WoS-id: 000257325000025
Scopus-id: 2-s2.0-46349102280
| 66 | 75 |
| 293 | All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy | Coautor: Arrieta O., Hernández-Pedro N., Ordonez, G, Ortiz-Plata A., et al. | 2008 | TRANSL RES | WoS-id: 000257695100006
Scopus-id: 2-s2.0-46349090170
| 25 | 29 |
| 294 | Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients - An open lobel phase II study | 1ᵉʳ autor: Arrieta O., Martinez-Barrera L., Trevino, S, Guzman E., et al. | 2008 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000258447300012
Scopus-id: 2-s2.0-58149136604
| 27 | 29 |
| 295 | Importance of the preoperative evaluation of multifocal and multicentric breast cancer with magnetic resonance imaging in women with dense parenchyma | Coautor: Arrieta O., Olivas-Maguregui S., Villasenor-Navarro, Y, Ferrari-Carballo T., et al. | 2008 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000263051700004
Scopus-id: 2-s2.0-59149092601
| 11 | 15 |
| 296 | The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis | 1ᵉʳ autor: Arrieta O., Cacho B., Morales-Espinosa D., Ruelas-Villavicencio A., et al. | 2007 | Bmc Cancer | WoS-id: 000244494600001
Scopus-id: 2-s2.0-33847676832
| 91 | 100 |
| 297 | Clinical and Pathological Factors Associated with the Development of Hepatocellular Carcinoma in Patients with Hepatitis Virus-related Cirrhosis: A Long-term Follow-up Study | Coautor: Arrieta O., Rodríguez-Díaz J.L., Rosas-Camargo V., Vega-Vega O., et al. | 2007 | CLIN ONCOL-UK | WoS-id: 000245149900007
Scopus-id: 2-s2.0-33847010888
| 25 | 34 |
| 298 | Human chorionic gonadotropin as an angiogenic factor in breast cancer during pregnancy | Coautor y autor de correspondencia: Arrieta O., Michel R.M., Aguilar J.L. | 2007 | MEDICAL HYPOTHESES | WoS-id: 000245701300020
Scopus-id: 2-s2.0-33847056196
| 15 | 17 |
| 299 | Prognostic factors in gallbladder and biliary tract cancer | 2ᵒ autor: Arrieta O., Gómez-Roel X., León-Rodríguez E. | 2007 | MEDICAL ONCOLOGY | WoS-id: 000246767100010
Scopus-id: 2-s2.0-34548805794
| 5 | 7 |
| 300 | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors | Coautor: Arrieta Ó., Candelaria M., Gallardo-Rincón D., Arce C., et al. | 2007 | ANNALS OF ONCOLOGY | WoS-id: 000250437200016
Scopus-id: 2-s2.0-34548395116
| 220 | 247 |
| 301 | Predictors of mortality and adverse outcome in elderly high-risk patients undergoing percutaneous coronary intervention | Coautor: Arrieta O., Malpica E.M., Duque M.A.P., Castellanos J., et al. | 2007 | ARCHIVOS DE CARDIOLOGIA DE MEXICO | Scopus-id: 2-s2.0-35348847752
| 0 | 9 |
| 302 | Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer | Coautor: Arrieta O., Fernández-Sánchez M., Gamboa-Dominguez A., Uribe N., et al. | 2006 | MEDICAL ONCOLOGY | WoS-id: 000237371600003
Scopus-id: 2-s2.0-33646885250
| 29 | 32 |
| 303 | Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis | 1ᵉʳ autor: Arrieta O., Rodriguez-Diaz J.L., Rosas-Camargo V., Morales-Espinosa D., et al. | 2006 | CANCER | WoS-id: 000241171300015
Scopus-id: 2-s2.0-33750049023
| 29 | 34 |
| 304 | Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas | Coautor: Arrieta O., Tena-Suck M.L., Salinas-Lara C., Arce-Arellano R.I., et al. | 2006 | CLINICAL NEUROLOGY AND NEUROSURGERY | WoS-id: 000241319200008
Scopus-id: 2-s2.0-33748797678
| 35 | 41 |
| 305 | Response of negative estrogen-receptor hepatocarcinoma to tamoxifen, and survival of non-resectable patients | Coautor: Arrieta O., García-Leiva J., Gamboa-Domínguez A., Ceron-Lizarraga T., et al. | 2006 | Annals Of Hepatology | Scopus-id: 2-s2.0-33845407475
| 0 | 6 |
| 306 | Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice | 1ᵉʳ autor: Arrieta O., García-Navarrete R., Zúñiga S., Ordóñez G., et al. | 2005 | EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | WoS-id: 000227249200007
Scopus-id: 2-s2.0-14844312018
| 34 | 37 |
| 307 | Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma | 1ᵉʳ autor: Arrieta O., Guevara P., Escobar E., García-Navarrete R., et al. | 2005 | BRITISH JOURNAL OF CANCER | WoS-id: 000228146900012
Scopus-id: 2-s2.0-18044364823
| 103 | 110 |
| 308 | Tumour necrosis factor a and troponin T as predictors of poor prognosis in patients with stable heart failure | 2ᵒ autor: Arrieta O., Rodríguez-Reyna T.S., Castillo-Martínez L., Orea-Tejeda A., et al. | 2005 | CLINICAL AND INVESTIGATIVE MEDICINE | WoS-id: 000229232100005
Scopus-id: 2-s2.0-14144252954
| 21 | 22 |
| 309 | Tubal occlusion causing infertility due to an excessive inflammatory response in patients with predisposition for keloid formation | 2ᵒ autor y autor de correspondencia: Arrieta O., García-Ulloa A.C. | 2005 | MEDICAL HYPOTHESES | WoS-id: 000231837300014
Scopus-id: 2-s2.0-27244436109
| 8 | 10 |
| 310 | Prolonged exposure to lead lowers the threshold of pentylenetetrazole- induced seizures in rats | 1ᵉʳ autor: Arrieta O., Palencia G., García-Arenas G., Morales-Espinosa D., et al. | 2005 | Epilepsia | WoS-id: 000232005800005
Scopus-id: 2-s2.0-27244456166
| 14 | 13 |
| 311 | Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma | 2ᵒ autor: Arrieta O., Moreno-Luna L.E., Garcia-Leiva J., Martínez B., et al. | 2005 | Bmc Cancer | WoS-id: 000233888500001
Scopus-id: 2-s2.0-27744434462
| 44 | 54 |
| 312 | Interstitial transfer factor as adjuvant immunotherapy for experimental glioma | Coautor: Arrieta O., Pineda B., Estrada-Parra S., Pedraza-Medina B., et al. | 2005 | J EXP CLIN CANC RES | WoS-id: 000234813700009
Scopus-id: 2-s2.0-31344463427
| 23 | 28 |
| 313 | Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas | 2ᵒ autor: Arrieta O., Martínez-Rumayor A., Guevara P., Escobar E., et al. | 2004 | CANCER LETTERS | WoS-id: 000223770200014
Scopus-id: 2-s2.0-4344594389
| 20 | 24 |
| 314 | Angiotensin II, cell proliferation and angiogenesis regulator: Biologic and therapeutic implications in cancer | Coautor: Arrieta O., Escobar E., Rodríguez-Reyna T.S., Sotelo J. | 2004 | CURRENT VASCULAR PHARMACOLOGY | Scopus-id: 2-s2.0-4444264480
| 0 | 138 |
| 315 | Elevation of plasmatic endothelin in patients with heart failure | 2ᵒ autor: Arrieta O., Galindo-Fraga A., Castillo-Martínez L., Narváez R., et al. | 2003 | Archives Of Medical Research | WoS-id: 000186601700004
Scopus-id: 2-s2.0-1542604459
| 5 | 7 |
| 316 | Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma | 1ᵉʳ autor: Arrieta O., Garcia E., Guevara P., Garcia-Navarrete R., et al. | 2002 | CANCER | WoS-id: 000176305600017
Scopus-id: 2-s2.0-0037096867
| 65 | 70 |
| 317 | Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma | 1ᵉʳ autor: Arrieta O., Guevara P., Tamariz J., Rembao D., et al. | 2002 | INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY | WoS-id: 000176446300005
Scopus-id: 2-s2.0-0036309005
| 18 | 21 |
| 318 | Effect of thalidomide in different tumors in rodents | 2ᵒ autor: Arrieta O., Palencia W., Ríos C., Altagracia M., et al. | 2002 | Journal of Experimental Therapeutics and Oncology | Scopus-id: 2-s2.0-0036081073
| 0 | 10 |
| 319 | AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma | 2ᵒ autor: Arrieta O., Rivera E., Guevara P., Duarte-Rojo A., et al. | 2001 | BRITISH JOURNAL OF CANCER | WoS-id: 000172319300027
Scopus-id: 2-s2.0-0035798467
| 81 | 89 |
| 320 | Paradoxical effect of aspirin on the growth of C6 rat glioma and on time of development of ENU-induced tumors of the nervous system | 1ᵉʳ autor: Arrieta O., Guevara P., Reyes S., Palencia G., et al. | 2001 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | Scopus-id: 2-s2.0-0034787747
| 0 | 12 |
| 321 | Interstitial quinacrine for elimination of abnormal tissue; therapy of experimental glioma | Coautor: Arrieta O., Sotelo J., Guevara P., Reyes S. | 2000 | Surgery | WoS-id: 000089154100009
Scopus-id: 2-s2.0-0033817755
| 13 | 12 |
| 322 | Pharmacological treatment of septic shock | 1ᵉʳ autor: Arrieta O., Rodriguez-Reyna T.S., Sotelo J. | 2000 | EXPERT OPIN THER PAT | Scopus-id: 2-s2.0-0034101834
| 0 | 7 |
| 323 | Protective effect of pentoxifylline plus thalidomide against septic shock in mice | 1ᵉʳ autor: Arrieta O., Ortiz-Reyes A., Rembao D., Calvillo M., et al. | 1999 | INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY | WoS-id: 000079118100002
Scopus-id: 2-s2.0-0032973519
| 13 | 12 |
| 324 | Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine | 1ᵉʳ autor: Arrieta O., Guevara P., Reyes S., Ortiz A., et al. | 1998 | EUROPEAN JOURNAL OF CANCER | WoS-id: 000077444900028
Scopus-id: 2-s2.0-0032403589
| 40 | 42 |
| 325 | The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival | Coautor: Arrieta O., Turcott J.G., Martinez-Samano J.E., Cardona A.F., et al. | | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | WoS-id: 000542421100001
Scopus-id: 2-s2.0-85086782015
| 10 | 10 |
| 326 | Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019?Infected Patients With Lung Cancer | Coautor: Arrieta O., Rolfo C., Cardona A.F., Ruiz-Patiño A., et al. | | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 000582730500016
Scopus-id: 2-s2.0-85088961178
| 9 | 11 |
| 327 | S-allylcysteine induces cytotoxic effects in two human lung cancer cell lines via induction of oxidative damage, downregulation of Nrf2 and NF-?B, and apoptosis | Coautor: Arrieta O., Orozco-Morales M., Hernández-Pedro N.Y., Barrios-Bernal P., et al. | | ANTI-CANCER DRUGS | WoS-id: 000639301900002
Scopus-id: 2-s2.0-85099721934
| 9 | 10 |
| 328 | Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer | 1ᵉʳ autor: Arrieta O., Varela-Santoyo E., Cardona A.F., Sánchez-Reyes R., et al. | | CLINICAL LUNG CANCER | WoS-id: 000723160600003
Scopus-id: 2-s2.0-85105095204
| 5 | 8 |
ID's SCOPUS 
ORCID's 